0001347123 2026-01-01 2026-03-31 0001347123 2026-05-08 0001347123 2026-03-31 0001347123 2025-12-31 0001347123 2025-01-01 2025-03-31 0001347123 us-gaap:CommonStockMember 2024-12-31 0001347123 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001347123 us-gaap:RetainedEarningsMember 2024-12-31 0001347123 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001347123 2024-12-31 0001347123 us-gaap:CommonStockMember 2025-12-31 0001347123 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001347123 us-gaap:RetainedEarningsMember 2025-12-31 0001347123 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001347123 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001347123 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001347123 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001347123 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001347123 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001347123 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001347123 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001347123 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001347123 us-gaap:CommonStockMember 2025-03-31 0001347123 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001347123 us-gaap:RetainedEarningsMember 2025-03-31 0001347123 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001347123 2025-03-31 0001347123 us-gaap:CommonStockMember 2026-03-31 0001347123 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001347123 us-gaap:RetainedEarningsMember 2026-03-31 0001347123 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001347123 cik0001347123:WiSECRTSystemMember 2026-01-01 2026-03-31 0001347123 cik0001347123:WiSECRTSystemMember 2025-01-01 2025-03-31 0001347123 cik0001347123:SurgicalToolKitsMember 2026-01-01 2026-03-31 0001347123 cik0001347123:SurgicalToolKitsMember 2025-01-01 2025-03-31 0001347123 cik0001347123:BatteryReplacementsMember 2026-01-01 2026-03-31 0001347123 cik0001347123:BatteryReplacementsMember 2025-01-01 2025-03-31 0001347123 us-gaap:CashMember 2026-03-31 0001347123 us-gaap:CashMember 2025-12-31 0001347123 us-gaap:MoneyMarketFundsMember 2026-03-31 0001347123 us-gaap:MoneyMarketFundsMember 2025-12-31 0001347123 us-gaap:AssetBackedSecuritiesMember 2026-03-31 0001347123 us-gaap:AssetBackedSecuritiesMember 2025-12-31 0001347123 us-gaap:CommercialPaperMember 2026-03-31 0001347123 us-gaap:CommercialPaperMember 2025-12-31 0001347123 us-gaap:CorporateBondSecuritiesMember 2026-03-31 0001347123 us-gaap:CorporateBondSecuritiesMember 2025-12-31 0001347123 us-gaap:USTreasurySecuritiesMember 2026-03-31 0001347123 us-gaap:USTreasurySecuritiesMember 2025-12-31 0001347123 us-gaap:AssetBackedSecuritiesMember 2026-01-01 2026-03-31 0001347123 us-gaap:CommercialPaperMember 2026-01-01 2026-03-31 0001347123 us-gaap:CorporateBondSecuritiesMember 2026-01-01 2026-03-31 0001347123 us-gaap:USTreasurySecuritiesMember 2026-01-01 2026-03-31 0001347123 us-gaap:AssetBackedSecuritiesMember 2025-01-01 2025-12-31 0001347123 us-gaap:CommercialPaperMember 2025-01-01 2025-12-31 0001347123 us-gaap:CorporateBondSecuritiesMember 2025-01-01 2025-12-31 0001347123 us-gaap:USTreasurySecuritiesMember 2025-01-01 2025-12-31 0001347123 2025-01-01 2025-12-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001347123 us-gaap:EquipmentMember 2026-03-31 0001347123 us-gaap:EquipmentMember 2025-12-31 0001347123 cik0001347123:ComputerSoftwareMember 2026-03-31 0001347123 cik0001347123:ComputerSoftwareMember 2025-12-31 0001347123 us-gaap:LeaseholdImprovementsMember 2026-03-31 0001347123 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001347123 us-gaap:ConstructionInProgressMember 2026-03-31 0001347123 us-gaap:ConstructionInProgressMember 2025-12-31 0001347123 2025-01-31 0001347123 cik0001347123:RunwayGrowthFinanceCorpMember 2026-03-31 0001347123 cik0001347123:RunwayGrowthFinanceCorpMember 2025-12-31 0001347123 cik0001347123:RunwayGrowthFinanceCorpMember 2026-01-01 2026-03-31 0001347123 cik0001347123:RunwayGrowthFinanceCorpMember 2025-01-01 2025-03-31 0001347123 us-gaap:ConvertiblePreferredStockMember 2026-03-31 0001347123 us-gaap:ConvertiblePreferredStockMember 2025-12-31 0001347123 cik0001347123:CommonStockWarrantsMember 2026-03-31 0001347123 cik0001347123:N2013EquityIncentivePlanMember 2026-03-31 0001347123 cik0001347123:N2021EquityIncentivePlanMember 2026-03-31 0001347123 cik0001347123:OutsideOf2021EquityIncentivePlanMember 2026-03-31 0001347123 cik0001347123:Plan2021Member 2021-10-14 0001347123 cik0001347123:Plan2021Member us-gaap:CommonStockMember 2026-03-31 0001347123 cik0001347123:Plan2021Member 2026-03-31 0001347123 cik0001347123:Plan2013Member us-gaap:CommonStockMember 2026-03-31 0001347123 cik0001347123:StockOptionsMember 2026-01-01 2026-03-31 0001347123 cik0001347123:StockOptionsMember 2025-01-01 2025-03-31 0001347123 cik0001347123:UnvestedStockOptionsMember 2026-03-31 0001347123 cik0001347123:UnvestedStockOptionsMember 2026-01-01 2026-03-31 0001347123 us-gaap:StockOptionMember 2025-12-31 0001347123 us-gaap:StockOptionMember 2025-01-01 2025-12-31 0001347123 us-gaap:StockOptionMember 2026-01-01 2026-03-31 0001347123 us-gaap:StockOptionMember 2026-03-31 0001347123 srt:MinimumMember 2025-01-01 2025-03-31 0001347123 srt:MaximumMember 2025-01-01 2025-03-31 0001347123 srt:MinimumMember 2026-01-01 2026-03-31 0001347123 srt:MaximumMember 2026-01-01 2026-03-31 0001347123 cik0001347123:CostOfGoodsMember 2026-01-01 2026-03-31 0001347123 cik0001347123:CostOfGoodsMember 2025-01-01 2025-03-31 0001347123 cik0001347123:ResearchAndDevelopmentMember 2026-01-01 2026-03-31 0001347123 cik0001347123:ResearchAndDevelopmentMember 2025-01-01 2025-03-31 0001347123 cik0001347123:GeneralAndAdministrativeMember 2026-01-01 2026-03-31 0001347123 cik0001347123:GeneralAndAdministrativeMember 2025-01-01 2025-03-31 0001347123 cik0001347123:June302016Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:June302016Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:June302016Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:October302017Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:October302017Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:October302017Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:February282018Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:February282018Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:February282018Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:August262019Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:August262019Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:August262019Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:March132020Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:March132020Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:March132020Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:March252020Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:March252020Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:March252020Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:February122021Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:February122021Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:February122021Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:June252021Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:June252021Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:June252021Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:August162021Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:August162021Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:August162021Member us-gaap:WarrantMember 2026-03-31 0001347123 cik0001347123:October42021Member us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 cik0001347123:October42021Member us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 cik0001347123:October42021Member us-gaap:WarrantMember 2026-03-31 0001347123 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001347123 us-gaap:WarrantMember 2026-03-31 0001347123 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001347123 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001347123 us-gaap:StockOptionMember 2026-01-01 2026-03-31 0001347123 us-gaap:StockOptionMember 2025-01-01 2025-03-31 0001347123 country:US 2026-01-01 2026-03-31 0001347123 country:US 2025-01-01 2025-03-31 0001347123 cik0001347123:InternationalMember 2026-01-01 2026-03-31 0001347123 cik0001347123:InternationalMember 2025-01-01 2025-03-31 0001347123 cik0001347123:EngineeringAndDevelopmentMember 2026-01-01 2026-03-31 0001347123 cik0001347123:EngineeringAndDevelopmentMember 2025-01-01 2025-03-31 0001347123 cik0001347123:ClinicalAndRegulatoryMember 2026-01-01 2026-03-31 0001347123 cik0001347123:ClinicalAndRegulatoryMember 2025-01-01 2025-03-31 0001347123 cik0001347123:SellingAndMarketingMember 2026-01-01 2026-03-31 0001347123 cik0001347123:SellingAndMarketingMember 2025-01-01 2025-03-31 0001347123 cik0001347123:Plan2021Member 2026-05-01 2026-05-06 iso4217:USD shares iso4217:USD shares pure false Q1 2026 --12-31 0001347123 10-Q true 2026-03-31 false 000-56671 EBR SYSTEMS, INC. DE 57-1164669 480 Oakmead Parkway Sunnyvale CA 94085 408 720-1906 None. None. Yes Yes Non-accelerated Filer true true false false 45056436 6558000 5794000 23315000 47395000 5152000 2320000 15492000 13789000 1977000 2490000 1550000 1323000 54044000 73111000 2604000 2604000 8770000 5477000 12263000 12613000 1006000 1011000 1058000 1864000 541000 546000 80286000 97226000 5765000 7049000 5002000 5605000 207000 212000 1097000 1182000 12071000 14048000 240000 184000 17397000 16520000 41040000 40886000 70748000 71638000 0.0001 0.0001 600000000 600000000 45055736 45055736 45025917 45025917 5000 5000 427891000 426852000 -419290000 -402216000 932000 947000 9538000 25588000 80286000 97226000 2362000 2178000 184000 6417000 5419000 9939000 4363000 16356000 9782000 -16172000 -9782000 1316000 1397000 414000 633000 -8000 -902000 -772000 -17074000 -10554000 -17074000 -10554000 -0.38 -0.38 -0.28 -0.28 45038351 45038351 37254117 37254117 -17074000 -10554000 -49000 -11000 -34000 -15000 -11000 -17089000 -10565000 37107620 4000 376936000 -353459000 874000 24355000 182012 264000 264000 505000 505000 -10554000 -10554000 -11000 -11000 37289632 4000 377705000 -364013000 863000 14559000 45025917 5000 426852000 -402216000 947000 25588000 28573 132000 132000 907000 907000 1246 -17074000 -17074000 -15000 -15000 45055736 5000 427891000 -419290000 932000 9538000 -17074000 -10554000 125000 79000 -154000 -153000 350000 297000 907000 505000 137000 214000 2832000 339000 897000 2161000 -770000 -234000 269000 -136000 -1314000 -686000 -822000 -1321000 -4000 -4000 792000 311000 -20251000 -13564000 3290000 60000 19415000 13655000 4757000 4311000 20882000 17906000 22000 132000 264000 132000 242000 1000 1000 764000 4585000 8398000 6918000 9162000 11503000 1167000 1249000 1701000 517000 12838000 <p id="xdx_805_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z0jAjijfMKHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Note 1 - <span id="xdx_82A_zvwmZMmMKVEe">Business and organization</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Business overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">EBR Systems, Inc. and subsidiaries (collectively, “EBR”, “we”, “our” or the “Company”) is a United States based medical device company that developed the WiSE CRT System (“WiSE”), an implantable cardiac device able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads. This implantable device delivers left-ventricle endocardial pacing for cardiac resynchronization therapy (“CRT”), without the use of wires or leads going into the heart. On April 11, 2025, the Company received notification that the U.S. Food and Drug Administration (“FDA”) has completed its review of the premarket approval application (“PMA”) and approved WiSE for commercial distribution in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: #333333; background-color: white">The Company completed its initial public offering of </span>CHESS Depository Interests (“CDIs”) <span style="color: #333333; background-color: white">and began trading on the Australian Securities Exchange (“ASX”) on November 24, 2021, under the symbol “EBR”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company operates wholly owned foreign subsidiary entities in Australia, EBR Systems (AUST) Pty Ltd (“EBR-AU”), and the United Kingdom, EBR Systems (UK) Limited (“EBR-UK”), which establish clinical trials in Australia and the United Kingdom, respectively, and work on intellectual property development. EBR-AU was incorporated on February 23, 2017, and EBR-UK was incorporated on July 31, 2015. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Reverse stock split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company held a Special Meeting of Stockholders (the "Special Meeting") on March 11, 2026. In that Special Meeting, stockholders of the Company approved an amendment to the Company’s amended and restated certificate of incorporation (the "Amendment”) to effect the reverse stock split of its common stock and the transmutation ratio of CDIs to common stock at a ratio in the range of 1-for-5 to 1-for-20, with such ratio to be determined in the discretion of the Company’s board of directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s board of directors in its sole discretion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Pursuant to such authority granted by the Company’s stockholders, the Company’s board of directors approved a <span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20260101__20260331_zik3ECtZgIHa" title="Reverse stock split">1-for-10 (1:10)</span> reverse stock split (the "Reverse Stock Split”) of the Company’s common stock and the filing of the Amendment to effectuate the Reverse Stock Split. The Amendment was filed with the Secretary of State of the State of Delaware and the Reverse Stock Split became effective in accordance with the terms of the Amendment at 4:00 a.m. Eastern Time on April 1, 2026 (the "Effective Time”), and the Company commenced normal trading on ASX on April 13, 2026, on a post-split basis under the existing ticker symbol “EBR”. The Amendment provided that, at the Effective Time, every ten shares of the Company’s issued and outstanding common stock automatically combined into one issued and outstanding share of common stock, without any change in par value per share, which remained at $0.0001. The Company’s CDIs were not consolidated as part of the Reverse Stock Split, but rather the transmutation ratio of the CDIs to shares was changed from 1-to-1 to 10-to-1. See Note 10, “Common Stock” for additional information on CDIs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The number of authorized shares of common stock remained at 600 million shares. As a result of the Reverse Stock Split, proportionate adjustments were made to the per share exercise price and/or the number of shares issuable upon the exercise or vesting of all outstanding stock options and warrants, which resulted in a proportional decrease in the number of shares of the Company’s common stock reserved for issuance upon exercise or vesting of such stock options and warrants and a proportional increase in the exercise price of all such stock options and warrants. The Company does not need to recognize any additional compensation expense as a result of the adjustment to outstanding stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In addition, the number of shares reserved for issuance under the Company’s equity incentive plan immediately prior to the Effective Time was reduced proportionately.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">No fractional shares were issued as a result of the Reverse Stock Split. Any stockholder who would have been entitled to receive a fractional share as a result of the process was entitled to the rounding up of the fractional share to the nearest whole number.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Reverse Stock Split has been retroactively adjusted throughout these unaudited condensed consolidated financial statements for all periods presented, including exercise prices and share data. As a result of the Reverse Stock Split, the </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Company reclassified approximately $<span id="xdx_90F_eus-gaap--NetSharesReclassifiedToMandatorilyRedeemableCapitalStockValue_pn3n3_c20260101__20260331_zfbESTpG76eh" title="Reclassified amount">41</span> thousand between common stock par value and additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 1-for-10 (1:10) 41000 <p id="xdx_80C_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zeIQEM1wZI91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Note 2 - <span id="xdx_823_zoax2ZYgUcC4">Going concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities during the normal course of business. At each reporting period, the Company evaluates whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern within one year after the date that the financial statements are issued. The Company’s evaluation entails analyzing prospective operating budgets and forecasts for expectations of its cash needs and comparing those needs to the current cash, cash equivalents and marketable securities balances. The Company is required to make certain additional disclosures if it concludes substantial doubt exists and it is not alleviated by its plans or when its plans alleviate substantial doubt about its ability to continue as a going concern. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">For the three months ended March 31, 2026 and 2025, the Company incurred a net loss of $17.1 <span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20260101__20260331_z94SnEs9V81d" style="display: none" title="Net loss">17,074</span> million and $10.6 <span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20250101__20250331_zKvQUpO1GLe1" style="display: none" title="Net loss">10,554</span> million, respectively. During the three months ended March 31, 2026 and 2025, the Company had negative cash flows from operations of $20.3 <span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20260101__20260331_zT5Z92NIOmhk" style="display: none" title="Net cash used in operating activities">20,251</span> million and $13.6 <span id="xdx_904_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20250101__20250331_zKi1OipgZS7a" style="display: none" title="Net cash used in operating activities">13,564</span> million, respectively. As of March 31, 2026, the Company had working capital of $<span id="xdx_905_ecustom--WorkingCapital_iI_pn3n3_dm_c20260331_zdWGmn7FMlW8" title="Working capital">42.0</span> million and accumulated deficit of $419.3 <span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20260331_zUW1tn9M891d" style="display: none" title="Accumulated deficit">419,290</span> million. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Based on the Company’s cash, cash equivalents, and marketable securities as of March 31, 2026, and its expectation to generate operating losses and negative operating cash flows in the foreseeable future, as well as potential liquidity to become less than the $2.5 million required under its existing debt covenants during the next twelve months, there exists substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements. The Company was in compliance with its debt covenant as of March 31, 2026. Upon the occurrence of a breach of debt covenants, Runway Growth Finance Corp may, at its option, declare all obligations immediately due and payable. In an effort to alleviate these conditions, the Company will need to raise capital through the issuance of additional common stock or borrowings from financial institutions. The Company’s ability to obtain additional capital in the equity capital markets is subject to several factors, including market and economic conditions, the Company’s performance, and investor sentiment with respect to the Company and its industry; however, no assurance can be given as to whether additional needed financing will be available on terms acceptable to the Company, or at all. The unaudited condensed consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> -17074000 -10554000 -20251000 -13564000 42000000.0 -419290000 <p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zwyDXNYPUn63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Note 3 - <span id="xdx_82B_zQlo36BXb54b">Summary of significant accounting policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zirpJa2WF6Df" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i><span id="xdx_862_zuTXyE7QVD3h">Basis of presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">These unaudited condensed consolidated financial statements as of March 31, 2026, and for the three months ended March 31, 2026 and 2025, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the included disclosures are adequate, and the accompanying unaudited condensed consolidated financial statements contain all adjustments which are necessary for a fair presentation of our unaudited condensed consolidated financial position as of March 31, 2026, unaudited condensed consolidated results of operations and comprehensive loss for the three months ended March 31, 2026 and 2025, and unaudited condensed consolidated cash flows for the three months ended March 31, 2026 and 2025. The unaudited condensed consolidated results of operations for the three months ended March 31, 2026, are not necessarily indicative of the consolidated results of operations that may be expected for the year ending December 31, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">In the third quarter of 2025, the Company changed the presentation of Note 15, “Segment information” to better align with the information the chief operating decision maker (“CODM”) uses to allocate resources and assess operating performance. Prior period segment information was updated to conform to the current period presentation. See Note 15 “Segment information” for additional disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">In the fourth quarter of 2025, the Company changed its rounding presentation of these condensed consolidated financial statements to the nearest thousands, except share or per share data or as otherwise indicated. The accompanying notes to the financial statements are denominated in millions of dollars. The change in rounding presentation has been applied to all prior year amounts presented. In certain circumstances, this change adjusted previously reported balances, however, these changes were not significant, and no other changes were made to previously reported financial information. Additionally, certain columns and rows within the financial statements and tables presented may not add due to rounding. Percentages have been calculated from the underlying whole-dollar amounts for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_841_eus-gaap--UseOfEstimates_zdSWkkDQNft6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i><span id="xdx_869_z6Cem1pePN65">Use of estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The preparation of financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include the fair value of stock-based awards issued. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by management. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zWHaXeWJuGif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i><span id="xdx_866_zX3n3sonDeEc">Significant Accounting Policies</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white">The Company’s significant accounting policies are disclosed in the 2025 Annual Report on Form 10-K. There have been no material changes to these accounting policies, except as noted below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_z4IzykhgZA4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86A_zDWvvxH4Q1Ok">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes revenue from contracts with customers disaggregated by product for the three months ended March 31, 2026 and 2025 (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zFjLqpUdrto9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8BC_zH8ofWxlGvAj" style="display: none">Schedule of disaggregated revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="6" style="white-space: nowrap; color: black; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">WiSE CRT System</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--WiSECRTSystemMember_z8LpYf30kN7a" title="Total revenue">2,320</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--WiSECRTSystemMember_zAz59J3zJ5lj" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Surgical tool kits<br/> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--SurgicalToolKitsMember_zPsJahSIPpzk" title="Total revenue">20</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--SurgicalToolKitsMember_zQLbRAvNR0Ia" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 1pt">Battery replacements</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_907_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--BatteryReplacementsMember_zbWpHoj3I8C9" title="Total revenue">22</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--BatteryReplacementsMember_zzu6WZMVE6n5" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: 9pt; padding-left: 9pt">Total revenue</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20260101__20260331_zPTShM85QWTb" title="Total revenue">2,362</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_904_eus-gaap--Revenues_pn3n3_c20250101__20250331_zBHTXjsrtDt9" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zVOSHSCAocIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_ecustom--DeferredRevenuePolicyTextBlock_zmiM6CB9FFck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i><span id="xdx_863_zLKbUKmEUX17">Deferred revenue</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The timing of revenue recognition for WiSE </span>CRT System and battery replacements <span style="background-color: white">differ from the timing of invoicing to customers. The Company invoices customers upon shipment or delivery of WiSE</span> and battery replacements to the customer<span style="background-color: white">, while the revenue is recognized upon completion of the procedure. Therefore, the Company recognizes a contract liability resulting from the timing of revenue recognition and invoicing. Deferred revenue is equivalent to billings for WiSE performance obligations that are unsatisfied as of the balance sheet date. The Company expects to recognize revenue from these unfulfilled performance obligations within one year or less. The movement in the deferred revenue balance </span>during the three ended March 31, 2026 and 2025 <span style="background-color: white">was as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"></span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DeferredRevenueByArrangementDisclosureTextBlock_pn3n3_zPMy7P9QxaV4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8B5_zx4JsyhOyJB5" style="display: none">Schedule of deferred revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Balance, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90B_eus-gaap--DeferredRevenue_iS_pn3n3_c20260101__20260331_ztdrvNyB5YPh" title="Balance, beginning of period">502</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_900_eus-gaap--DeferredRevenue_iS_pn3n3_c20250101__20250331_zIdyTjKkRJWh" title="Balance, beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Deferral of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--DeferralOfRevenue_pn3n3_c20260101__20260331_zhomVorSGo48" title="Deferral of revenue">2,940</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--DeferralOfRevenue_pn3n3_c20250101__20250331_zFE1LN7saaA4" title="Deferral of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0507">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Recognition of revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--RecognitionOfDeferredRevenue_pn3n3_c20260101__20260331_zFgcygXzR7dl" title="Recognition of revenue">(2,342</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--RecognitionOfDeferredRevenue_pn3n3_c20250101__20250331_zSRXU0lyh00g" title="Recognition of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--DeferredRevenue_iE_pn3n3_c20260101__20260331_zVA6ll9hkM08" title="Balance, end of period">1,100</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--DeferredRevenue_iE_pn3n3_c20250101__20250331_zc5bvtwLhIVc" title="Balance, end of period"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zr4b2zpUAsKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_841_ecustom--InterestIncomePolicyTextBlock_zinxTz7XWOUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_zHlEgDcnhZvb">Interest Income</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s interest income was generated from its cash, cash equivalent, and marketable securities, including accretion of discounts. The following table provides a summary of the components of interest income for the three months ended March 31, 2026 and 2025 (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--InterestIncomeAndInterestExpenseDisclosureTableTextBlock_pn3n3_zfvs8XTsA7Tl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zXCvpae1hx53" style="display: none">Schedule of interest income</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20260101__20260331_z59QeHDe1wK1" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20250101__20250331_zUIlX6Lz9eQa" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="6" style="white-space: nowrap; color: black; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr id="xdx_405_eus-gaap--InterestIncomeOther_maIIOzTAK_zx5VzjM1vLQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Interest income</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right">277</td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right">419</td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AccretionOfDiscountOnMarketableSecuritiesNet_maIIOzTAK_zfz1iY6clAui" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Accretion of discount on marketable securities, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">214</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--InterestIncomeOperating_iT_mtIIOzTAK_zkqWdXLRnHJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: 9pt; padding-left: 9pt">Total interest income</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">414</td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">633</td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zvx9VWWZiBTf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i></i></b></p> <p id="xdx_844_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zKjEUA3WJKj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i><span id="xdx_862_zu1srRSQVI8f">Recently adopted accounting pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In July 2025, the FASB issued ASU 2025-05, <i>Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets</i>, which amends ASC 326-20 to provide a practical expedient related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606. The practical expedient permits all entities to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset. The amendments are effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company adopted this ASU in the first quarter of 2026, on a prospective basis and elected the practical expedient for the calculation of current expected credit losses. The adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNrQt7i3Z7Kh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i><span id="xdx_864_zVqHyYmJRIHc">Recently issued accounting pronouncements not yet adopted</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In December 2025, the FASB issued <i>ASU 2025-12, Codification Improvements</i>. ASU 2025-12 addresses suggestions received from stakeholders regarding the Accounting Standards Codification and makes other incremental improvements to U.S. GAAP. The update represents changes to the Codification that clarify, correct errors or make other improvements to a variety of topics. ASU 2025-12 is effective for fiscal years beginning after December 15, 2026, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In December 2025, the FASB issued ASU 2025-11, <i>Interim Reporting (Topic 270) Narrow-Scope Improvements. </i>The ASU is intended to clarify the applicability of interim reporting guidance and addresses the form and content of interim financial statements and interim disclosure requirements. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In September 2025, the FASB issued ASU 2025-06, "<i>Intangible - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software."  </i>This ASU is intended to simplify the capitalization guidance by removing all references to software development project stages and introducing a more judgment-based approach. The amendments in this ASU are effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: #333333; background-color: white">In November 2024, the FASB issued ASU 2024-03, <i>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</i>. The amendments in ASU 2024-03 address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. This guidance is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. </span>In January 2025, the FASB issued an update 2025-01 “<i>Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date”, </i>which revises the effective date of ASU 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. <span style="color: #333333; background-color: white">The Company is currently evaluating the impact of this standard on its disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zirpJa2WF6Df" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i><span id="xdx_862_zuTXyE7QVD3h">Basis of presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">These unaudited condensed consolidated financial statements as of March 31, 2026, and for the three months ended March 31, 2026 and 2025, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the included disclosures are adequate, and the accompanying unaudited condensed consolidated financial statements contain all adjustments which are necessary for a fair presentation of our unaudited condensed consolidated financial position as of March 31, 2026, unaudited condensed consolidated results of operations and comprehensive loss for the three months ended March 31, 2026 and 2025, and unaudited condensed consolidated cash flows for the three months ended March 31, 2026 and 2025. The unaudited condensed consolidated results of operations for the three months ended March 31, 2026, are not necessarily indicative of the consolidated results of operations that may be expected for the year ending December 31, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">In the third quarter of 2025, the Company changed the presentation of Note 15, “Segment information” to better align with the information the chief operating decision maker (“CODM”) uses to allocate resources and assess operating performance. Prior period segment information was updated to conform to the current period presentation. See Note 15 “Segment information” for additional disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">In the fourth quarter of 2025, the Company changed its rounding presentation of these condensed consolidated financial statements to the nearest thousands, except share or per share data or as otherwise indicated. The accompanying notes to the financial statements are denominated in millions of dollars. The change in rounding presentation has been applied to all prior year amounts presented. In certain circumstances, this change adjusted previously reported balances, however, these changes were not significant, and no other changes were made to previously reported financial information. Additionally, certain columns and rows within the financial statements and tables presented may not add due to rounding. Percentages have been calculated from the underlying whole-dollar amounts for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_841_eus-gaap--UseOfEstimates_zdSWkkDQNft6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i><span id="xdx_869_z6Cem1pePN65">Use of estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The preparation of financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include the fair value of stock-based awards issued. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by management. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zWHaXeWJuGif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i><span id="xdx_866_zX3n3sonDeEc">Significant Accounting Policies</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white">The Company’s significant accounting policies are disclosed in the 2025 Annual Report on Form 10-K. There have been no material changes to these accounting policies, except as noted below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_z4IzykhgZA4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86A_zDWvvxH4Q1Ok">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes revenue from contracts with customers disaggregated by product for the three months ended March 31, 2026 and 2025 (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zFjLqpUdrto9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8BC_zH8ofWxlGvAj" style="display: none">Schedule of disaggregated revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="6" style="white-space: nowrap; color: black; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">WiSE CRT System</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--WiSECRTSystemMember_z8LpYf30kN7a" title="Total revenue">2,320</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--WiSECRTSystemMember_zAz59J3zJ5lj" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Surgical tool kits<br/> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--SurgicalToolKitsMember_zPsJahSIPpzk" title="Total revenue">20</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--SurgicalToolKitsMember_zQLbRAvNR0Ia" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 1pt">Battery replacements</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_907_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--BatteryReplacementsMember_zbWpHoj3I8C9" title="Total revenue">22</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--BatteryReplacementsMember_zzu6WZMVE6n5" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: 9pt; padding-left: 9pt">Total revenue</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20260101__20260331_zPTShM85QWTb" title="Total revenue">2,362</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_904_eus-gaap--Revenues_pn3n3_c20250101__20250331_zBHTXjsrtDt9" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zVOSHSCAocIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zFjLqpUdrto9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8BC_zH8ofWxlGvAj" style="display: none">Schedule of disaggregated revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="6" style="white-space: nowrap; color: black; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">WiSE CRT System</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--WiSECRTSystemMember_z8LpYf30kN7a" title="Total revenue">2,320</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--WiSECRTSystemMember_zAz59J3zJ5lj" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Surgical tool kits<br/> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--SurgicalToolKitsMember_zPsJahSIPpzk" title="Total revenue">20</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--SurgicalToolKitsMember_zQLbRAvNR0Ia" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 1pt">Battery replacements</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_907_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--ProductOrServiceAxis__custom--BatteryReplacementsMember_zbWpHoj3I8C9" title="Total revenue">22</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--ProductOrServiceAxis__custom--BatteryReplacementsMember_zzu6WZMVE6n5" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: 9pt; padding-left: 9pt">Total revenue</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20260101__20260331_zPTShM85QWTb" title="Total revenue">2,362</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_904_eus-gaap--Revenues_pn3n3_c20250101__20250331_zBHTXjsrtDt9" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 2320000 20000 22000 2362000 <p id="xdx_845_ecustom--DeferredRevenuePolicyTextBlock_zmiM6CB9FFck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i><span id="xdx_863_zLKbUKmEUX17">Deferred revenue</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The timing of revenue recognition for WiSE </span>CRT System and battery replacements <span style="background-color: white">differ from the timing of invoicing to customers. The Company invoices customers upon shipment or delivery of WiSE</span> and battery replacements to the customer<span style="background-color: white">, while the revenue is recognized upon completion of the procedure. Therefore, the Company recognizes a contract liability resulting from the timing of revenue recognition and invoicing. Deferred revenue is equivalent to billings for WiSE performance obligations that are unsatisfied as of the balance sheet date. The Company expects to recognize revenue from these unfulfilled performance obligations within one year or less. The movement in the deferred revenue balance </span>during the three ended March 31, 2026 and 2025 <span style="background-color: white">was as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"></span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DeferredRevenueByArrangementDisclosureTextBlock_pn3n3_zPMy7P9QxaV4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8B5_zx4JsyhOyJB5" style="display: none">Schedule of deferred revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Balance, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90B_eus-gaap--DeferredRevenue_iS_pn3n3_c20260101__20260331_ztdrvNyB5YPh" title="Balance, beginning of period">502</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_900_eus-gaap--DeferredRevenue_iS_pn3n3_c20250101__20250331_zIdyTjKkRJWh" title="Balance, beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Deferral of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--DeferralOfRevenue_pn3n3_c20260101__20260331_zhomVorSGo48" title="Deferral of revenue">2,940</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--DeferralOfRevenue_pn3n3_c20250101__20250331_zFE1LN7saaA4" title="Deferral of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0507">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Recognition of revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--RecognitionOfDeferredRevenue_pn3n3_c20260101__20260331_zFgcygXzR7dl" title="Recognition of revenue">(2,342</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--RecognitionOfDeferredRevenue_pn3n3_c20250101__20250331_zSRXU0lyh00g" title="Recognition of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--DeferredRevenue_iE_pn3n3_c20260101__20260331_zVA6ll9hkM08" title="Balance, end of period">1,100</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--DeferredRevenue_iE_pn3n3_c20250101__20250331_zc5bvtwLhIVc" title="Balance, end of period"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zr4b2zpUAsKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DeferredRevenueByArrangementDisclosureTextBlock_pn3n3_zPMy7P9QxaV4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8B5_zx4JsyhOyJB5" style="display: none">Schedule of deferred revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Balance, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90B_eus-gaap--DeferredRevenue_iS_pn3n3_c20260101__20260331_ztdrvNyB5YPh" title="Balance, beginning of period">502</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_900_eus-gaap--DeferredRevenue_iS_pn3n3_c20250101__20250331_zIdyTjKkRJWh" title="Balance, beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Deferral of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--DeferralOfRevenue_pn3n3_c20260101__20260331_zhomVorSGo48" title="Deferral of revenue">2,940</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--DeferralOfRevenue_pn3n3_c20250101__20250331_zFE1LN7saaA4" title="Deferral of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0507">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Recognition of revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--RecognitionOfDeferredRevenue_pn3n3_c20260101__20260331_zFgcygXzR7dl" title="Recognition of revenue">(2,342</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--RecognitionOfDeferredRevenue_pn3n3_c20250101__20250331_zSRXU0lyh00g" title="Recognition of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--DeferredRevenue_iE_pn3n3_c20260101__20260331_zVA6ll9hkM08" title="Balance, end of period">1,100</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--DeferredRevenue_iE_pn3n3_c20250101__20250331_zc5bvtwLhIVc" title="Balance, end of period"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 502000 2940000 -2342000 1100000 <p id="xdx_841_ecustom--InterestIncomePolicyTextBlock_zinxTz7XWOUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_zHlEgDcnhZvb">Interest Income</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s interest income was generated from its cash, cash equivalent, and marketable securities, including accretion of discounts. The following table provides a summary of the components of interest income for the three months ended March 31, 2026 and 2025 (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--InterestIncomeAndInterestExpenseDisclosureTableTextBlock_pn3n3_zfvs8XTsA7Tl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zXCvpae1hx53" style="display: none">Schedule of interest income</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20260101__20260331_z59QeHDe1wK1" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20250101__20250331_zUIlX6Lz9eQa" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="6" style="white-space: nowrap; color: black; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr id="xdx_405_eus-gaap--InterestIncomeOther_maIIOzTAK_zx5VzjM1vLQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Interest income</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right">277</td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right">419</td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AccretionOfDiscountOnMarketableSecuritiesNet_maIIOzTAK_zfz1iY6clAui" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Accretion of discount on marketable securities, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">214</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--InterestIncomeOperating_iT_mtIIOzTAK_zkqWdXLRnHJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: 9pt; padding-left: 9pt">Total interest income</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">414</td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">633</td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zvx9VWWZiBTf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i></i></b></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--InterestIncomeAndInterestExpenseDisclosureTableTextBlock_pn3n3_zfvs8XTsA7Tl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zXCvpae1hx53" style="display: none">Schedule of interest income</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20260101__20260331_z59QeHDe1wK1" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20250101__20250331_zUIlX6Lz9eQa" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="6" style="white-space: nowrap; color: black; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr id="xdx_405_eus-gaap--InterestIncomeOther_maIIOzTAK_zx5VzjM1vLQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Interest income</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right">277</td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right">419</td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AccretionOfDiscountOnMarketableSecuritiesNet_maIIOzTAK_zfz1iY6clAui" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Accretion of discount on marketable securities, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">214</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--InterestIncomeOperating_iT_mtIIOzTAK_zkqWdXLRnHJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt; text-indent: 9pt; padding-left: 9pt">Total interest income</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">414</td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">633</td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 277000 419000 137000 214000 414000 633000 <p id="xdx_844_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zKjEUA3WJKj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i><span id="xdx_862_zu1srRSQVI8f">Recently adopted accounting pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In July 2025, the FASB issued ASU 2025-05, <i>Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets</i>, which amends ASC 326-20 to provide a practical expedient related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606. The practical expedient permits all entities to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset. The amendments are effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company adopted this ASU in the first quarter of 2026, on a prospective basis and elected the practical expedient for the calculation of current expected credit losses. The adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNrQt7i3Z7Kh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i><span id="xdx_864_zVqHyYmJRIHc">Recently issued accounting pronouncements not yet adopted</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In December 2025, the FASB issued <i>ASU 2025-12, Codification Improvements</i>. ASU 2025-12 addresses suggestions received from stakeholders regarding the Accounting Standards Codification and makes other incremental improvements to U.S. GAAP. The update represents changes to the Codification that clarify, correct errors or make other improvements to a variety of topics. ASU 2025-12 is effective for fiscal years beginning after December 15, 2026, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In December 2025, the FASB issued ASU 2025-11, <i>Interim Reporting (Topic 270) Narrow-Scope Improvements. </i>The ASU is intended to clarify the applicability of interim reporting guidance and addresses the form and content of interim financial statements and interim disclosure requirements. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In September 2025, the FASB issued ASU 2025-06, "<i>Intangible - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software."  </i>This ASU is intended to simplify the capitalization guidance by removing all references to software development project stages and introducing a more judgment-based approach. The amendments in this ASU are effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited condensed consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: #333333; background-color: white">In November 2024, the FASB issued ASU 2024-03, <i>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</i>. The amendments in ASU 2024-03 address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. This guidance is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. </span>In January 2025, the FASB issued an update 2025-01 “<i>Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date”, </i>which revises the effective date of ASU 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. <span style="color: #333333; background-color: white">The Company is currently evaluating the impact of this standard on its disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_808_eus-gaap--CashCashEquivalentsAndMarketableSecuritiesTextBlock_zGOAKS1ZtgJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Note 4 - <span id="xdx_828_zVSbV3sh3vZ8">Cash, cash equivalents, and marketable securities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within our unaudited condensed consolidated balance sheets as of March 31, 2026 and March 31, 2025, to the total of such amounts as presented in the unaudited condensed consolidated statements of cash flows <span style="background-color: white">(in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfReconciliationOfCashCashEquivalentAndRestrictedCashTableTextBlock_pn3n3_zPt6fTUPBlm4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B6_zZJv2nOfdy02" style="display: none">Schedule reconciliation of cash, cash equivalents, and restricted cash</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_499_20260331_zVEApVHWsVMd" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td> </td><td style="padding-bottom: 1pt"> </td> <td id="xdx_493_20250331_zqy0PmgmxoGa" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">March 31, <br/>2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td> </td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; vertical-align: middle">March 31, <br/>2025</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_402_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzyKQ_zRJK3E6JSfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">6,558</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 1%"> </td><td style="width: 1%">$</td> <td style="text-align: right; width: 15%">8,899</td> <td style="width: 1%"> </td></tr> <tr id="xdx_40A_eus-gaap--RestrictedCashNoncurrent_iI_pn3n3_maCCERCzyKQ_zKRNflk7sZu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted cash, noncurrent</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,604</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">2,604</td> <td> </td></tr> <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzyKQ_zglgYvZBS9hj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 12.8pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,162</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td> </td><td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">11,503</td> <td> </td></tr> </table> <p id="xdx_8A9_zZs7BFjhSNml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Cash, cash equivalents, and marketable securities consisted of the following as of March 31, 2026 and December 31, 2025 (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_pn3n3_zaenleDT3JZa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8B3_zuxo4GTUflJ1" style="display: none">Schedule of cash and cash equivalents</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">March 31, <br/>2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">December 31, <br/>2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash and cash equivalents:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; width: 64%">Cash</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zZLNBxzIspmg" title="Total cash and cash equivalents">3,251</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zmp4Tf3bJgZc" title="Total cash and cash equivalents">1,386</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Money market funds</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zTW00nkAMXa" title="Total cash and cash equivalents">3,307</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zjTgZubs4YY5" title="Total cash and cash equivalents">4,408</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total cash and cash equivalents</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20260331_z6Izii4QImz" title="Total cash and cash equivalents">6,558</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20251231_zveOh64GeBv8" title="Total cash and cash equivalents">5,794</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Marketable securities, short-term:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left">Asset backed securities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zwEucApQn486" title="Total marketable securities, short-term">1,008</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_z58pIlurbdIg" title="Total marketable securities, short-term">1,012</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Commercial paper</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zuUR5xEpeSSf" title="Total marketable securities, short-term">1,783</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_ztH6Gq5fnIBf" title="Total marketable securities, short-term">9,125</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zI6Iu5eswCz1" title="Total marketable securities, short-term">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zP7q48r2VM3f" title="Total marketable securities, short-term">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">US Treasury securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zXYVepI64M2f" title="Total marketable securities, short-term">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zc2R4FoduNv8" title="Total marketable securities, short-term">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total marketable securities, short-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331_zhCsvhOAWwL5" title="Total marketable securities, short-term">23,315</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231_zUUR6UCTWx55" title="Total marketable securities, short-term">47,395</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Marketable securities, long-term:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Asset backed securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_z1CrgxH0h7de" title="Total marketable securities, long-term">1,006</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zo87CDHDc958" title="Total marketable securities, long-term">1,011</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total marketable securities, long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20260331_z8UMy0du1sD3" title="Total marketable securities, long-term">1,006</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20251231_zsd0SVA5pNT5" title="Total marketable securities, long-term">1,011</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total cash, cash equivalents, and marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn3n3_c20260331_zNVp2zNoFnIa" title="Total cash, cash equivalents, and marketable securities">30,879</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn3n3_c20251231_zHEwdkQ5jXKd" title="Total cash, cash equivalents, and marketable securities">54,200</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zhPKRpQ5ecJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three-month period ended March 31, 2026 and 2025, marketable securities were sold or matured for proceeds of $24.2 million and $18.0 million, respectively. The Company recorded an immaterial amount of realized gain during the for the three months ended March 31, 2026 and 2025. See Note 5, “Fair value measurements” for additional information regarding the fair value of cash equivalents and marketable securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables summarizes the unrealized gains and losses related to the Company’s available-for-sale marketable securities, by major security type, as of March 31, 2026 and December 31, 2025 <span style="background-color: white">(in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"></span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zHPHUzwqjUy1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; text-indent: 16.85pt"><span id="xdx_8B5_zTv79w5VuaNb" style="display: none">Schedule of unrealized gains and losses</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">As of March 31, 2026</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Amortized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Cost</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Gains</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(losses)</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; color: black; text-align: left; text-indent: 16.85pt">Asset backed securities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zcsQhaWpUTEb" title="Amortized Cost">2,015</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_902_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zAqzdPWcCQ23" title="Unrealized Gains"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zmmNrgzFkpwl" title="Unrealized losses">(1</span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zrphZIXeon4d" title="Fair Value">2,014</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; text-indent: 16.85pt">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zFPSBiYkeDzk" title="Amortized Cost">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_z5zIkruqZ4lb"><span style="-sec-ix-hidden: xdx2ixbrl0606">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zvZriQvwXkMb"><span style="-sec-ix-hidden: xdx2ixbrl0607">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_900_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_ztY6wD6KIEml">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; text-indent: 16.85pt">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zWNNhPJTCdnd" title="Amortized Cost">12,670</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zk45QFvhDEKf">3</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zWCG42FsRSK8">(1</span></td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zobZPFleFz61">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 16.85pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z2TS6BoWCT51" title="Amortized Cost">7,848</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zayATIl6NUcg">4</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z5F9t1J5j3Yg"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90A_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zbZK4BUOAkpk">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt">Total marketable securities</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_900_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331_z46ksGQQbfSa" title="Amortized Cost">24,316</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331_z5aIEhQesWfa">7</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_903_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331_zjuflZfXq2hh">(2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331_ztVUAaRdGlIg">24,321</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; white-space: nowrap; color: black; text-align: left"> </td><td style="padding-bottom: 1pt; white-space: nowrap"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Amortized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Cost</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Gains</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(losses)</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; width: 40%">Marketable securities</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; text-indent: 16.65pt">Asset backed securities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zepn7bk2lDwa" title="Amortized Cost">2,022</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zAC0AyQ8nc7h">1</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zhsjzYAhQNG8"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zNy2FNxyPSAk">2,023</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; text-indent: 16.65pt">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zj61eFboKgji" title="Amortized Cost">9,120</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zmgSNrxpjzJj">5</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zau4knm8avVc"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_z2L6glWH9V7">9,125</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; text-indent: 16.65pt">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_z0RgsdRIevT1" title="Amortized Cost">18,148</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_z5a081zlnYBf">23</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zEpNaB4mmk0l"><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zjvZqlP6d3T5">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 16.65pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zcVkmk0N2yaa" title="Amortized Cost">19,062</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_905_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z961dOqVfBaf">25</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zogycwTJvDui"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_ztX6liV30oC6">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt">Total marketable securities</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_903_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231_zX3e8R8ssIP6" title="Amortized Cost">48,352</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231_zKghv0iCq2Ih">54</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231_z8iDfswAMu18"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231_zvwI7LRJFvMj">48,406</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zp0xTpPk0vE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The following table shows the unrealized losses and fair values for those marketable securities that were in an unrealized loss position as of March 31, 2026 and December 31, 2025, aggregated by major security type and the length of time the marketable securities have been in a continuous loss position (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--MarketableSecuritiesTextBlock_pn3n3_zbm8hpuRuq6a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B7_z5MBo0BSnzCj" style="display: none">Schedule of marketable securities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="22" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">As of March 31, 2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">In Loss Position for Less <br/> Than 12 Months</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">In Loss Position for 12 <br/> Months or Greater</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Total</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Asset backed securities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_905_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_z3YkDcvWhkaj" title="Loss Position for Less Than 12 Months, Fair Value">2,014</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zDMWwllyDWf4" title="Loss Position for Less Than 12 Months, Unrealized Losses">(1</span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">     <span id="xdx_90F_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zT9AoFSzuh8h" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">     <span id="xdx_90C_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zIS26g5kqY7d" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0659">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_908_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zcoAenU81Ygb" title="Total, Fair Value">2,014</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zalwU6O39MRb" title="Total, Unrealized Losses">(1</span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Commercial paper</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zMhM3y1604Hh" title="Loss Position for Less Than 12 Months, Fair Value">1,190</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zUutClbLnr7g" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0667">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_z2HEt5wAruIi" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0669">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zqPggyasj9Ri" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zJty8nzjjyz3" title="Total, Fair Value">1,190</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zRhyGWBl9CK5" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0675">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zHFyE2984r0a" title="Loss Position for Less Than 12 Months, Fair Value">4,572</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zK1eR1RS0SY8" title="Loss Position for Less Than 12 Months, Unrealized Losses">(1</span></td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zZonoe97zOD9" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0681">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_ztwQElYK8Ush" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0683">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zQi9HIaS7NRe" title="Total, Fair Value">4,572</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zP7nM0ZCtE7g" title="Total, Unrealized Losses">(1</span></td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">US Treasury Securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zBF8qkSSbTa2" title="Loss Position for Less Than 12 Months, Fair Value">352</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zf8UpQDnZt84" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zIjhcqVLLvPg" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0693">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z7c3mvJbTPM1" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0695">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z5MYuWfJJSUk" title="Total, Fair Value">352</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zMA3RjdpTJK4" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0699">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; padding-bottom: 2.5pt; text-indent: 7.65pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331_zUZqquHcsM8e" title="Loss Position for Less Than 12 Months, Fair Value">8,128</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331_z96mNKbi9Bwd" title="Loss Position for Less Than 12 Months, Unrealized Losses">(2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331_zCCUDxhwe14e" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331_zSUrDUJsZ8Va" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331_zdXPeSaDnBv2" title="Total, Fair Value">8,128</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331_zJhkQI1QlNj8" title="Total, Unrealized Losses">(2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="22" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">As of December 31, 2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">In Loss Position for Less <br/> Than 12 Months</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">In Loss Position for 12 <br/> Months or Greater</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Total</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; color: black; text-align: left">Commercial paper</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right"><span id="xdx_90D_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zpSstv6o2Hqi" title="Loss Position for Less Than 12 Months, Fair Value">1,000</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_90F_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zlIjRjlvFZMc" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_908_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zMz0DJejRj4j" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_906_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zfhjtQDtIk74" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right"><span id="xdx_900_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zPAPRdzCTGF8" title="Total, Fair Value">1,000</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_90A_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zzVwvepnkq2k" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0723">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Corporate Bonds</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_908_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zigM4Ai4Nb06" title="Loss Position for Less Than 12 Months, Fair Value">298</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_z84iDsQvWzug" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0727">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90D_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_ziIwhXFjF4O2" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zH2Aq6DIWGMd" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0731">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_znXsll1qkQAg" title="Total, Fair Value">298</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zUAiV6Lxol9i" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; color: black; padding-bottom: 2.5pt; text-indent: 7.65pt">Total</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_901_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20251231_zAaQZMV9KOEg" title="Loss Position for Less Than 12 Months, Fair Value">1,298</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20251231_zkHVbeIuyHKi" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0739">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20251231_zIkELbNaFCyh" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0741">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20251231_zsxFOvVOBkZ" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0743">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90B_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20251231_zJhlOGXY9X9h" title="Total, Fair Value">1,298</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20251231_zXGACBHzwdd7" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zhQQ18PZNAbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The contractual maturities of the Company’s marketable securities as of March 31, 2026, were as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--InvestmentsClassifiedByContractualMaturityDateTableTextBlock_pn3n3_zQ7VbnJ0Hsak" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BE_zDJScmzAfRJ9" style="display: none">Schedule of contractual maturities</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_496_20260331_zvmCoGm4arg" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_ecustom--OneYearOrLessMarketableSecurities_iI_pn3n3_maAFSSDz6Cg_zEqgVQ6Mu2H6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">One year or less</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">23,315</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--AfterTwoYearToThreeYearsMarketableSecurities_iI_pn3n3_maAFSSDz6Cg_zITUPV8juZr6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Two years to three years</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,006</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iTI_pn3n3_mtAFSSDz6Cg_zi6xVDvtRqQ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 12.8pt">Total minimum payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,321</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zXiyMSOxTgQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfReconciliationOfCashCashEquivalentAndRestrictedCashTableTextBlock_pn3n3_zPt6fTUPBlm4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B6_zZJv2nOfdy02" style="display: none">Schedule reconciliation of cash, cash equivalents, and restricted cash</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_499_20260331_zVEApVHWsVMd" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td> </td><td style="padding-bottom: 1pt"> </td> <td id="xdx_493_20250331_zqy0PmgmxoGa" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">March 31, <br/>2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td> </td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; vertical-align: middle">March 31, <br/>2025</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_402_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzyKQ_zRJK3E6JSfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">6,558</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 1%"> </td><td style="width: 1%">$</td> <td style="text-align: right; width: 15%">8,899</td> <td style="width: 1%"> </td></tr> <tr id="xdx_40A_eus-gaap--RestrictedCashNoncurrent_iI_pn3n3_maCCERCzyKQ_zKRNflk7sZu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted cash, noncurrent</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,604</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">2,604</td> <td> </td></tr> <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzyKQ_zglgYvZBS9hj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 12.8pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,162</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td> </td><td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">11,503</td> <td> </td></tr> </table> 6558000 8899000 2604000 2604000 9162000 11503000 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_pn3n3_zaenleDT3JZa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8B3_zuxo4GTUflJ1" style="display: none">Schedule of cash and cash equivalents</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">March 31, <br/>2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">December 31, <br/>2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash and cash equivalents:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; width: 64%">Cash</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zZLNBxzIspmg" title="Total cash and cash equivalents">3,251</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zmp4Tf3bJgZc" title="Total cash and cash equivalents">1,386</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Money market funds</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zTW00nkAMXa" title="Total cash and cash equivalents">3,307</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zjTgZubs4YY5" title="Total cash and cash equivalents">4,408</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total cash and cash equivalents</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20260331_z6Izii4QImz" title="Total cash and cash equivalents">6,558</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20251231_zveOh64GeBv8" title="Total cash and cash equivalents">5,794</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Marketable securities, short-term:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left">Asset backed securities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zwEucApQn486" title="Total marketable securities, short-term">1,008</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_z58pIlurbdIg" title="Total marketable securities, short-term">1,012</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Commercial paper</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zuUR5xEpeSSf" title="Total marketable securities, short-term">1,783</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_ztH6Gq5fnIBf" title="Total marketable securities, short-term">9,125</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zI6Iu5eswCz1" title="Total marketable securities, short-term">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zP7q48r2VM3f" title="Total marketable securities, short-term">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">US Treasury securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zXYVepI64M2f" title="Total marketable securities, short-term">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zc2R4FoduNv8" title="Total marketable securities, short-term">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total marketable securities, short-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20260331_zhCsvhOAWwL5" title="Total marketable securities, short-term">23,315</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20251231_zUUR6UCTWx55" title="Total marketable securities, short-term">47,395</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Marketable securities, long-term:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 1pt">Asset backed securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_z1CrgxH0h7de" title="Total marketable securities, long-term">1,006</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zo87CDHDc958" title="Total marketable securities, long-term">1,011</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total marketable securities, long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20260331_z8UMy0du1sD3" title="Total marketable securities, long-term">1,006</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20251231_zsd0SVA5pNT5" title="Total marketable securities, long-term">1,011</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total cash, cash equivalents, and marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn3n3_c20260331_zNVp2zNoFnIa" title="Total cash, cash equivalents, and marketable securities">30,879</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn3n3_c20251231_zHEwdkQ5jXKd" title="Total cash, cash equivalents, and marketable securities">54,200</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3251000 1386000 3307000 4408000 6558000 5794000 1008000 1012000 1783000 9125000 12672000 18171000 7852000 19087000 23315000 47395000 1006000 1011000 1006000 1011000 30879000 54200000 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zHPHUzwqjUy1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; text-indent: 16.85pt"><span id="xdx_8B5_zTv79w5VuaNb" style="display: none">Schedule of unrealized gains and losses</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">As of March 31, 2026</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Amortized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Cost</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Gains</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(losses)</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; color: black; text-align: left; text-indent: 16.85pt">Asset backed securities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zcsQhaWpUTEb" title="Amortized Cost">2,015</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_902_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zAqzdPWcCQ23" title="Unrealized Gains"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zmmNrgzFkpwl" title="Unrealized losses">(1</span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zrphZIXeon4d" title="Fair Value">2,014</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; text-indent: 16.85pt">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zFPSBiYkeDzk" title="Amortized Cost">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_z5zIkruqZ4lb"><span style="-sec-ix-hidden: xdx2ixbrl0606">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zvZriQvwXkMb"><span style="-sec-ix-hidden: xdx2ixbrl0607">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_900_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_ztY6wD6KIEml">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; text-indent: 16.85pt">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zWNNhPJTCdnd" title="Amortized Cost">12,670</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zk45QFvhDEKf">3</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zWCG42FsRSK8">(1</span></td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zobZPFleFz61">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 16.85pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z2TS6BoWCT51" title="Amortized Cost">7,848</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zayATIl6NUcg">4</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z5F9t1J5j3Yg"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90A_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zbZK4BUOAkpk">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt">Total marketable securities</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_900_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20260331_z46ksGQQbfSa" title="Amortized Cost">24,316</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20260101__20260331_z5aIEhQesWfa">7</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_903_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20260101__20260331_zjuflZfXq2hh">(2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20260331_ztVUAaRdGlIg">24,321</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; white-space: nowrap; color: black; text-align: left"> </td><td style="padding-bottom: 1pt; white-space: nowrap"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Amortized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Unrealized</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Cost</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Gains</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(losses)</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; width: 40%">Marketable securities</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; text-indent: 16.65pt">Asset backed securities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zepn7bk2lDwa" title="Amortized Cost">2,022</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zAC0AyQ8nc7h">1</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zhsjzYAhQNG8"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zNy2FNxyPSAk">2,023</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; text-indent: 16.65pt">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zj61eFboKgji" title="Amortized Cost">9,120</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zmgSNrxpjzJj">5</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zau4knm8avVc"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_z2L6glWH9V7">9,125</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; text-indent: 16.65pt">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_z0RgsdRIevT1" title="Amortized Cost">18,148</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_z5a081zlnYBf">23</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zEpNaB4mmk0l"><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zjvZqlP6d3T5">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 16.65pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zcVkmk0N2yaa" title="Amortized Cost">19,062</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_905_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z961dOqVfBaf">25</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_909_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zogycwTJvDui"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_ztX6liV30oC6">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 2.5pt">Total marketable securities</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_903_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_pn3n3_c20251231_zX3e8R8ssIP6" title="Amortized Cost">48,352</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_901_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_pn3n3_c20250101__20251231_zKghv0iCq2Ih">54</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20250101__20251231_z8iDfswAMu18"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90B_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_pn3n3_c20251231_zvwI7LRJFvMj">48,406</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 2015000 1000 2014000 1783000 1783000 12670000 3000 1000 12672000 7848000 4000 7852000 24316000 7000 2000 24321000 2022000 1000 2023000 9120000 5000 9125000 18148000 23000 18171000 19062000 25000 19087000 48352000 54000 48406000 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--MarketableSecuritiesTextBlock_pn3n3_zbm8hpuRuq6a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B7_z5MBo0BSnzCj" style="display: none">Schedule of marketable securities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="22" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">As of March 31, 2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">In Loss Position for Less <br/> Than 12 Months</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">In Loss Position for 12 <br/> Months or Greater</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Total</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Asset backed securities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_905_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_z3YkDcvWhkaj" title="Loss Position for Less Than 12 Months, Fair Value">2,014</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zDMWwllyDWf4" title="Loss Position for Less Than 12 Months, Unrealized Losses">(1</span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">     <span id="xdx_90F_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zT9AoFSzuh8h" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">     <span id="xdx_90C_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zIS26g5kqY7d" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0659">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_908_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zcoAenU81Ygb" title="Total, Fair Value">2,014</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember_zalwU6O39MRb" title="Total, Unrealized Losses">(1</span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Commercial paper</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zMhM3y1604Hh" title="Loss Position for Less Than 12 Months, Fair Value">1,190</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zUutClbLnr7g" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0667">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_z2HEt5wAruIi" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0669">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zqPggyasj9Ri" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zJty8nzjjyz3" title="Total, Fair Value">1,190</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zRhyGWBl9CK5" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0675">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Corporate bonds</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zHFyE2984r0a" title="Loss Position for Less Than 12 Months, Fair Value">4,572</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zK1eR1RS0SY8" title="Loss Position for Less Than 12 Months, Unrealized Losses">(1</span></td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zZonoe97zOD9" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0681">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_ztwQElYK8Ush" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0683">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zQi9HIaS7NRe" title="Total, Fair Value">4,572</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zP7nM0ZCtE7g" title="Total, Unrealized Losses">(1</span></td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">US Treasury Securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zBF8qkSSbTa2" title="Loss Position for Less Than 12 Months, Fair Value">352</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zf8UpQDnZt84" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zIjhcqVLLvPg" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0693">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z7c3mvJbTPM1" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0695">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_z5MYuWfJJSUk" title="Total, Fair Value">352</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zMA3RjdpTJK4" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0699">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; padding-bottom: 2.5pt; text-indent: 7.65pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20260331_zUZqquHcsM8e" title="Loss Position for Less Than 12 Months, Fair Value">8,128</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20260331_z96mNKbi9Bwd" title="Loss Position for Less Than 12 Months, Unrealized Losses">(2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20260331_zCCUDxhwe14e" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20260331_zSUrDUJsZ8Va" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20260331_zdXPeSaDnBv2" title="Total, Fair Value">8,128</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20260331_zJhkQI1QlNj8" title="Total, Unrealized Losses">(2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="22" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">As of December 31, 2025</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">In Loss Position for Less <br/> Than 12 Months</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">In Loss Position for 12 <br/> Months or Greater</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Total</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td><td style="white-space: nowrap; color: black; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Unrealized <br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; color: black; text-align: left">Commercial paper</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right"><span id="xdx_90D_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zpSstv6o2Hqi" title="Loss Position for Less Than 12 Months, Fair Value">1,000</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_90F_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zlIjRjlvFZMc" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_908_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zMz0DJejRj4j" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_906_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zfhjtQDtIk74" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right"><span id="xdx_900_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zPAPRdzCTGF8" title="Total, Fair Value">1,000</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 9%; color: black; text-align: right">     <span id="xdx_90A_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember_zzVwvepnkq2k" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0723">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Corporate Bonds</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_908_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zigM4Ai4Nb06" title="Loss Position for Less Than 12 Months, Fair Value">298</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_z84iDsQvWzug" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0727">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90D_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_ziIwhXFjF4O2" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zH2Aq6DIWGMd" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0731">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_znXsll1qkQAg" title="Total, Fair Value">298</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember_zUAiV6Lxol9i" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; color: black; padding-bottom: 2.5pt; text-indent: 7.65pt">Total</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_901_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_iI_pn3n3_c20251231_zAaQZMV9KOEg" title="Loss Position for Less Than 12 Months, Fair Value">1,298</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_iNI_pn3n3_di_c20251231_zkHVbeIuyHKi" title="Loss Position for Less Than 12 Months, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0739">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_iI_pn3n3_c20251231_zIkELbNaFCyh" title="Loss Position for 12 Months or Greater, Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0741">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90C_eus-gaap--DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_iI_pn3n3_c20251231_zsxFOvVOBkZ" title="Loss Position for 12 Months or Greater, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0743">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90B_eus-gaap--HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue_iI_pn3n3_c20251231_zJhlOGXY9X9h" title="Total, Fair Value">1,298</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedLossPosition_iNI_pn3n3_di_c20251231_zXGACBHzwdd7" title="Total, Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 2014000 1000 2014000 1000 1190000 1190000 4572000 1000 4572000 1000 352000 352000 8128000 2000 8128000 2000 1000000 1000000 298000 298000 1298000 1298000 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--InvestmentsClassifiedByContractualMaturityDateTableTextBlock_pn3n3_zQ7VbnJ0Hsak" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash, cash equivalents, and marketable securities (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BE_zDJScmzAfRJ9" style="display: none">Schedule of contractual maturities</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_496_20260331_zvmCoGm4arg" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_ecustom--OneYearOrLessMarketableSecurities_iI_pn3n3_maAFSSDz6Cg_zEqgVQ6Mu2H6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">One year or less</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">23,315</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--AfterTwoYearToThreeYearsMarketableSecurities_iI_pn3n3_maAFSSDz6Cg_zITUPV8juZr6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Two years to three years</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,006</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iTI_pn3n3_mtAFSSDz6Cg_zi6xVDvtRqQ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 12.8pt">Total minimum payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,321</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 23315000 1006000 24321000 <p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_zfKvPHRK6Sn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 5 - <span id="xdx_827_zV5Qa2d8IFBj">Fair value measurement</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Management’s assessment of the significance of a particular input to the fair value measurement requires judgement and may affect the valuation of financial assets and liabilities and their placement within the three-tier fair value hierarchy. As of March 31, 2026 and December 31, 2025, the fair value measurement of the Company’s financial assets measured on a recurring basis were as follows (in thousands):</span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_pn3n3_zVg3wg6nIAIj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair value measurement (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; color: black; text-align: left"><span id="xdx_8B0_znNLPVbEJsBk" style="display: none">Schedule of fair value, liabilities measured on recurring basis</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Fair Values as of March 31, 2026</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 1</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 2</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 3</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Total</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black">Cash equivalents</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left; width: 40%">Money market funds</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFg2aiG2bcd7" title="Cash equivalents">3,307</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_903_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z9aHgQNVAAc3" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGuY7vsgPHk" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0765">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGjy8Rl5eAn" title="Cash equivalents">3,307</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black">Marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Asset backed securities</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsLSMv2rbINk" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFUatqJ9XsEc" title="Marketable securities">2,014</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0QkK4Vt9jU7" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYXWQjAuoH7j" title="Marketable securities">2,014</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; color: black; text-align: left">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqA8Gvp83Dxj" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziWh4Eqefsih" title="Marketable securities">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7T90qhIJ3Z" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0781">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgg4b6YmtRoe" title="Marketable securities">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Corporate bonds</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zeXMwksXStZi" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_znVhRblKPkQl" title="Marketable securities">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2b9rkMoGDe4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0789">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpDy1HCjhJij" title="Marketable securities">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 18pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX3SCqDNMxAg" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIssXo6W1ixk" title="Marketable securities">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zupJWRquEfMb" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90C_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOLQo1R4oj32" title="Marketable securities">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt">Total</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_902_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zTSLeON2mR2h" title="Total">3,307</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_904_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6DCYqusqwJg" title="Total">24,321</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_902_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziCMEKAb9yb9" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_909_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0DjChE5gPAg" title="Total">27,628</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Fair Values as of December 31, 2025</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 1</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 2</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 3</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Total</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"><span style="color: black">Cash equivalents</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left; width: 40%">Money market funds</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z407LD2mOaPc" title="Cash equivalents">4,408</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z30kYrJwhJ1h" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztZPMv7mrbY" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z1v9ORceJyz" title="Cash equivalents">4,408</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black">Marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Asset backed securities</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z9ABEiiyowT4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zP2xRniawHgl" title="Marketable securities">2,023</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zL5IZAzwXUU6" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvnqwvt3x3Jc" title="Marketable securities">2,023</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; color: black; text-align: left">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_903_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLLZFrcKZsT5" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGUj5vKwhmph" title="Marketable securities">9,125</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zNWS1h1JLR3e" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zAiAk6PZd6S7" title="Marketable securities">9,125</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Corporate bonds</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk5uUh41Ecb4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0834">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zM0OqSYpXYf5" title="Marketable securities">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFhwaES7SThj" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zPxVflT0gm33" title="Marketable securities">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 18pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zBOFGXq9xWG5" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zraF7asKFsv3" title="Marketable securities">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90C_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zoBaDZj4Mmf4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z83mmdCXFfsd" title="Marketable securities">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt">Total</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0sBXtT5Oyd2" title="Total">4,408</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXwkNZmxspwf" title="Total">48,406</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_909_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zuMHV6YTEK91" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMQ4JER5eHU1" title="Total">52,814</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8AA_z2eeyI6OMRNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In the Company’s unaudited condensed consolidated balance sheets, the carrying values of accounts and other receivables, other assets, accounts payable and accrued expenses approximated their fair values due to the nature and relatively short maturities. The fair value of debt approximates its carrying value as it is variable rate debt or has relatively short maturities. There are no other financial assets and liabilities that require fair value hierarchy measurements and disclosures for the periods presented. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_pn3n3_zVg3wg6nIAIj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair value measurement (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; color: black; text-align: left"><span id="xdx_8B0_znNLPVbEJsBk" style="display: none">Schedule of fair value, liabilities measured on recurring basis</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Fair Values as of March 31, 2026</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 1</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 2</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 3</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Total</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black">Cash equivalents</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left; width: 40%">Money market funds</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFg2aiG2bcd7" title="Cash equivalents">3,307</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_903_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z9aHgQNVAAc3" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGuY7vsgPHk" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0765">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGjy8Rl5eAn" title="Cash equivalents">3,307</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black">Marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Asset backed securities</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsLSMv2rbINk" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFUatqJ9XsEc" title="Marketable securities">2,014</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0QkK4Vt9jU7" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYXWQjAuoH7j" title="Marketable securities">2,014</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; color: black; text-align: left">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqA8Gvp83Dxj" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziWh4Eqefsih" title="Marketable securities">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7T90qhIJ3Z" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0781">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgg4b6YmtRoe" title="Marketable securities">1,783</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Corporate bonds</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zeXMwksXStZi" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_znVhRblKPkQl" title="Marketable securities">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2b9rkMoGDe4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0789">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpDy1HCjhJij" title="Marketable securities">12,672</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 18pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX3SCqDNMxAg" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIssXo6W1ixk" title="Marketable securities">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_908_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zupJWRquEfMb" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90C_eus-gaap--MarketableSecurities_iI_pn3n3_c20260331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOLQo1R4oj32" title="Marketable securities">7,852</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt">Total</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_902_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zTSLeON2mR2h" title="Total">3,307</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_904_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6DCYqusqwJg" title="Total">24,321</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_902_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziCMEKAb9yb9" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_909_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20260331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0DjChE5gPAg" title="Total">27,628</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Fair Values as of December 31, 2025</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 1</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 2</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Level 3</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">Total</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"><span style="color: black">Cash equivalents</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left; width: 40%">Money market funds</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z407LD2mOaPc" title="Cash equivalents">4,408</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z30kYrJwhJ1h" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztZPMv7mrbY" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z1v9ORceJyz" title="Cash equivalents">4,408</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black">Marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Asset backed securities</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z9ABEiiyowT4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zP2xRniawHgl" title="Marketable securities">2,023</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zL5IZAzwXUU6" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--AssetBackedSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvnqwvt3x3Jc" title="Marketable securities">2,023</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; color: black; text-align: left">Commercial paper</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_903_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLLZFrcKZsT5" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_901_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGUj5vKwhmph" title="Marketable securities">9,125</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zNWS1h1JLR3e" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CommercialPaperMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zAiAk6PZd6S7" title="Marketable securities">9,125</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Corporate bonds</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk5uUh41Ecb4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0834">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zM0OqSYpXYf5" title="Marketable securities">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFhwaES7SThj" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CorporateBondSecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zPxVflT0gm33" title="Marketable securities">18,171</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt; text-indent: 18pt">US Treasury securities</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zBOFGXq9xWG5" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zraF7asKFsv3" title="Marketable securities">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90C_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zoBaDZj4Mmf4" title="Marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_900_eus-gaap--MarketableSecurities_iI_pn3n3_c20251231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z83mmdCXFfsd" title="Marketable securities">19,087</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt">Total</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0sBXtT5Oyd2" title="Total">4,408</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXwkNZmxspwf" title="Total">48,406</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_909_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zuMHV6YTEK91" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20251231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMQ4JER5eHU1" title="Total">52,814</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 3307000 3307000 2014000 2014000 1783000 1783000 12672000 12672000 7852000 7852000 3307000 24321000 27628000 4408000 4408000 2023000 2023000 9125000 9125000 18171000 18171000 19087000 19087000 4408000 48406000 52814000 <p id="xdx_809_ecustom--CondensedConsolidatedBalanceSheetComponentsTextBlock_z4cOOwTZxfE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Note 6 - <span id="xdx_82D_zudZchGpvzpl">Condensed consolidated balance sheet components</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Accounts and other receivables, net</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts and other receivables includes amounts due from sales of Company’s product to customers, sales of materials to contract manufacturers, and reimbursements for leasehold improvements. Accounts and other receivables, net were as follows as of March 31, 2026 and December 31, 2025 <span style="background-color: white">(in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_pn3n3_zjBAzZCJIJi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zRDXNRFxLwOh" style="display: none">Schedule of non trade receivables</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20260331_zUONTihdiYyg" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20251231_zYE8LawVseCe" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_ecustom--TradeReceivables_iI_pn3n3_maUCRzXmv_zb4N4hKdNB7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Trade receivables</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,144</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">452</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NontradeReceivables_iI_pn3n3_maUCRzXmv_z8PrNrZrIou6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-trade receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">435</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--ReimbursementForLeaseholdImprovements_iI_pn3n3_maUCRzXmv_z2gVQP4avnL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Reimbursement for leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,573</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,714</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--UnbilledContractsReceivable_iTI_pn3n3_maURCzeub_mtUCRzXmv_zeannkoNdGcf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Accounts and other receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,152</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,320</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_pn3n3_di_msURCzeub_zYek7syx39ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: provision for credit losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--UnbilledReceivablesCurrent_iTI_pn3n3_mtURCzeub_zdfaPmmUAHMa" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 2.5pt">Accounts and other receivables, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,152</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,320</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zy83j0hgrIsj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">During the three months ended March 31, 2026 and 2025, the Company recorded <span id="xdx_90E_eus-gaap--ProvisionForOtherCreditLosses_pn3n3_do_c20260101__20260331_zwdEFpEWRiYi" title="Provision for other credit losses"><span id="xdx_901_eus-gaap--ProvisionForOtherCreditLosses_pn3n3_do_c20250101__20250331_zcWeZzT5Fh66" title="Provision for other credit losses">no</span></span> provision for credit losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Inventory</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory consisted of the following as of March 31, 2026 and December 31, 2025 <span style="background-color: white">(in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfInventoryConsistedTableTextBlock_pn3n3_zRoJsO5Uaozi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_zThepGyvFD75" style="display: none">Schedule of inventory consisted</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20260331_zekpZEksnqI6" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20251231_z7ICSTvRj7Gb" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pn3n3_maIGz2Kl_z6jb4Un0rWA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Raw materials</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,488</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,019</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIGz2Kl_zm2sCAoiMid" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,455</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,168</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maIGz2Kl_zVy3GZh8Yon6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,607</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,466</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryGross_iTI_pn3n3_mtIGz2Kl_maINzTq9_z0D6JCKwNl28" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; padding-bottom: 2.5pt">Inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,550</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,653</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--InventoryCurrent_iNI_pn3n3_di_maINzTq9_zPgPbG8x8Il3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Inventory – current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">15,492</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,789</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryNoncurrent_iTI_pn3n3_mtINzTq9_zvElFlS9aFje" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Inventory – noncurrent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,058</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,864</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zObTA6NiCb1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Property and equipment, net</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Property and equipment consisted of the following as of March 31, 2026 and December 31, 2025 (in thousands):</span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zejN9IGznije" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8B3_zxN0uxwUUhQ2" style="display: none">Schedule of property and equipment, net</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="white-space: nowrap; color: black; text-align: center">March 31,</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="white-space: nowrap; color: black; text-align: center">December 31,</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black">Equipment</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zvwaANPKCHL7" title="Total property and equipment">4,169</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zNJcBZnrdGz4" title="Total property and equipment">3,300</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Computer software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_zNlHvlqeylg6" title="Total property and equipment">596</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_zzBbjUjLjUo2" title="Total property and equipment">560</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Leasehold improvements</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwQzD7v9ODG" title="Total property and equipment">554</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwU8OQZXFRub" title="Total property and equipment">554</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Construction in progress</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zHI9uCV36hR7" title="Total property and equipment">6,802</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zirstkXFTWg1" title="Total property and equipment">4,289</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Total property and equipment</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331_zSn1gMSzxkuk" title="Total property and equipment">12,121</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231_ztJhj2Ku5iy7" title="Total property and equipment">8,703</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20260331_zjmcUZ5dkDvk" title="Less accumulated depreciation and amortization">(3,351</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20251231_z3Y6HyOOderc" title="Less accumulated depreciation and amortization">(3,226</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left; padding-bottom: 2.5pt">Total property and equipment, net</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20260331_z8Rm6MJsqoc" title="Total property and equipment, net">8,770</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20251231_zGdfDhw4SjWk" title="Total property and equipment, net">5,477</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zK9aiB7jBpea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026 and December 31, 2025, construction in progress pertains to tenant improvements for the Company’s new corporate headquarters, laboratory, and manufacturing facility in Santa Clara, California. Depreciation and amortization expense for the three months ended March 31, 2026 and 2025, was $<span id="xdx_90C_eus-gaap--DepreciationAndAmortization_pn3n3_dm_c20260101__20260331_zAODS6KwXkX2" title="Depreciation and amortization expense">0.1</span> million and $<span id="xdx_907_eus-gaap--DepreciationAndAmortization_pn3n3_dm_c20250101__20250331_z9ep2y3IwBIg" title="Depreciation and amortization expense">0.1 </span>million, respectively. There were <span id="xdx_90D_eus-gaap--GoodwillImpairmentLoss_pn3n3_do_c20260101__20260331_znqkUojxcyuc" title="Impairments loss"><span id="xdx_90A_eus-gaap--GoodwillImpairmentLoss_pn3n3_do_c20250101__20250331_zOJAljo8MiU8" title="Impairments loss">no</span></span> impairments recorded during the three months ended March 31, 2026 and 2025. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Accrued expenses and other liabilities </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses and other liabilities consisted of the following as of March 31, 2026 and December 31, 2025 <span style="background-color: white">(in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHoZN2iVGqx" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zCd2VSshxQfi" style="display: none">Schedule of accrued expenses and other liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20260331_z45tRrM0DmS4" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20251231_z8uy5THIJxqc" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALAOLzLzr_zDpehikSx2Wk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Accrued compensation and related liabilities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,925</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">4,049</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccruedDevelopmentExpenses_iI_pn3n3_maALAOLzLzr_zrDirB47Afxi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">354</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--AccruedWarrantyReserves_iI_pn3n3_maALAOLzLzr_z2VuyELFbBV8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued warranty reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">102</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredRevenue_iI_pn3n3_maALAOLzLzr_z5ut85ldsAs8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,100</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">502</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALAOLzLzr_z0ACX6E3WKib" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accrued other expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">587</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">515</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_pn3n3_mtALAOLzLzr_zjda7IZp0Qx8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 2.5pt">Accrued expenses and other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,002</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,605</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_z7Wkx68fB0G3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Changes in accrued warranty reserves were as follows during the three months ended March 31, 2026 and 2025 (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfWarrantyReservesTableTextBlock_pn3n3_zGpIK7jLspp5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 18pt"><span id="xdx_8BA_z6BXT5gNqdfb" style="display: none">Schedule of warranty</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20260101__20260331_zoHGG8YUPX06" title="Beginning of period">240</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90E_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20250101__20250331_z2H06erUdQ14" title="Beginning of period">692</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 18pt">Warranty reserve accrued during the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20260101__20260331_zMiBZyQaJlHi" title="Warranty reserve accrued during the period">84</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20250101__20250331_zx0btqiwRMB9" title="Warranty reserve accrued during the period"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 18pt">Settlement of warranty claims</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ProductWarrantyAccrualPayments_iN_pn3n3_di_c20260101__20260331_zzvSWhSAlFI4" title="Settlement of warranty claims">(83</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--ProductWarrantyAccrualPayments_iN_pn3n3_di_c20250101__20250331_zTsSHQ9llro1" title="Settlement of warranty claims">(166</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">End of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20260101__20260331_za0WqjsISTL3" title="End of period">241</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20250101__20250331_zoNTfqw8Zbg6" title="End of period">526</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warranty reserve - current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_ecustom--WarrantyReserveCurrent_pn3n3_c20260101__20260331_zJaVVf8HxB0l" title="Warranty reserve - current">102</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_ecustom--WarrantyReserveCurrent_pn3n3_c20250101__20250331_zYChDuW2Nqhi" title="Warranty reserve - current">526</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warranty reserve - noncurrent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_900_ecustom--WarrantyReserveNoncurrent_pn3n3_c20260101__20260331_zPGFKbzb98w8" title="Warranty reserve - noncurrent">139</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_ecustom--WarrantyReserveNoncurrent_pn3n3_c20250101__20250331_zjoYT7FbUzhk" title="Warranty reserve - noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0987">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z7n7zPPLYSA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_pn3n3_zjBAzZCJIJi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zRDXNRFxLwOh" style="display: none">Schedule of non trade receivables</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20260331_zUONTihdiYyg" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20251231_zYE8LawVseCe" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_ecustom--TradeReceivables_iI_pn3n3_maUCRzXmv_zb4N4hKdNB7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Trade receivables</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,144</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">452</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NontradeReceivables_iI_pn3n3_maUCRzXmv_z8PrNrZrIou6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-trade receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">435</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--ReimbursementForLeaseholdImprovements_iI_pn3n3_maUCRzXmv_z2gVQP4avnL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Reimbursement for leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,573</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,714</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--UnbilledContractsReceivable_iTI_pn3n3_maURCzeub_mtUCRzXmv_zeannkoNdGcf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Accounts and other receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,152</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,320</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_pn3n3_di_msURCzeub_zYek7syx39ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: provision for credit losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--UnbilledReceivablesCurrent_iTI_pn3n3_mtURCzeub_zdfaPmmUAHMa" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 2.5pt">Accounts and other receivables, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,152</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,320</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2144000 452000 435000 154000 2573000 1714000 5152000 2320000 5152000 2320000 0 0 <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfInventoryConsistedTableTextBlock_pn3n3_zRoJsO5Uaozi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_zThepGyvFD75" style="display: none">Schedule of inventory consisted</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20260331_zekpZEksnqI6" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20251231_z7ICSTvRj7Gb" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pn3n3_maIGz2Kl_z6jb4Un0rWA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Raw materials</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,488</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,019</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIGz2Kl_zm2sCAoiMid" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,455</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,168</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maIGz2Kl_zVy3GZh8Yon6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,607</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,466</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryGross_iTI_pn3n3_mtIGz2Kl_maINzTq9_z0D6JCKwNl28" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; padding-bottom: 2.5pt">Inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,550</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,653</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--InventoryCurrent_iNI_pn3n3_di_maINzTq9_zPgPbG8x8Il3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Inventory – current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">15,492</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,789</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryNoncurrent_iTI_pn3n3_mtINzTq9_zvElFlS9aFje" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Inventory – noncurrent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,058</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,864</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 2488000 2019000 9455000 9168000 4607000 4466000 16550000 15653000 -15492000 -13789000 1058000 1864000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zejN9IGznije" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8B3_zxN0uxwUUhQ2" style="display: none">Schedule of property and equipment, net</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="white-space: nowrap; color: black; text-align: center">March 31,</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="white-space: nowrap; color: black; text-align: center">December 31,</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2026</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">2025</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black">Equipment</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zvwaANPKCHL7" title="Total property and equipment">4,169</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zNJcBZnrdGz4" title="Total property and equipment">3,300</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Computer software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_zNlHvlqeylg6" title="Total property and equipment">596</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_zzBbjUjLjUo2" title="Total property and equipment">560</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Leasehold improvements</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwQzD7v9ODG" title="Total property and equipment">554</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwU8OQZXFRub" title="Total property and equipment">554</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Construction in progress</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zHI9uCV36hR7" title="Total property and equipment">6,802</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zirstkXFTWg1" title="Total property and equipment">4,289</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left">Total property and equipment</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20260331_zSn1gMSzxkuk" title="Total property and equipment">12,121</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20251231_ztJhj2Ku5iy7" title="Total property and equipment">8,703</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20260331_zjmcUZ5dkDvk" title="Less accumulated depreciation and amortization">(3,351</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20251231_z3Y6HyOOderc" title="Less accumulated depreciation and amortization">(3,226</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left; padding-bottom: 2.5pt">Total property and equipment, net</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20260331_z8Rm6MJsqoc" title="Total property and equipment, net">8,770</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20251231_zGdfDhw4SjWk" title="Total property and equipment, net">5,477</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 4169000 3300000 596000 560000 554000 554000 6802000 4289000 12121000 8703000 3351000 3226000 8770000 5477000 100000 100000 0 0 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHoZN2iVGqx" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zCd2VSshxQfi" style="display: none">Schedule of accrued expenses and other liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20260331_z45tRrM0DmS4" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20251231_z8uy5THIJxqc" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALAOLzLzr_zDpehikSx2Wk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Accrued compensation and related liabilities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,925</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">4,049</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccruedDevelopmentExpenses_iI_pn3n3_maALAOLzLzr_zrDirB47Afxi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued development expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">354</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--AccruedWarrantyReserves_iI_pn3n3_maALAOLzLzr_z2VuyELFbBV8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued warranty reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">102</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">185</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredRevenue_iI_pn3n3_maALAOLzLzr_z5ut85ldsAs8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,100</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">502</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALAOLzLzr_z0ACX6E3WKib" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accrued other expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">587</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">515</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_pn3n3_mtALAOLzLzr_zjda7IZp0Qx8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 2.5pt">Accrued expenses and other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,002</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,605</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2925000 4049000 288000 354000 102000 185000 1100000 502000 587000 515000 5002000 5605000 <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfWarrantyReservesTableTextBlock_pn3n3_zGpIK7jLspp5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Condensed consolidated balance sheet components (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 18pt"><span id="xdx_8BA_z6BXT5gNqdfb" style="display: none">Schedule of warranty</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20260101__20260331_zoHGG8YUPX06" title="Beginning of period">240</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90E_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20250101__20250331_z2H06erUdQ14" title="Beginning of period">692</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 18pt">Warranty reserve accrued during the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20260101__20260331_zMiBZyQaJlHi" title="Warranty reserve accrued during the period">84</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20250101__20250331_zx0btqiwRMB9" title="Warranty reserve accrued during the period"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 18pt">Settlement of warranty claims</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ProductWarrantyAccrualPayments_iN_pn3n3_di_c20260101__20260331_zzvSWhSAlFI4" title="Settlement of warranty claims">(83</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--ProductWarrantyAccrualPayments_iN_pn3n3_di_c20250101__20250331_zTsSHQ9llro1" title="Settlement of warranty claims">(166</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">End of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20260101__20260331_za0WqjsISTL3" title="End of period">241</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20250101__20250331_zoNTfqw8Zbg6" title="End of period">526</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warranty reserve - current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_ecustom--WarrantyReserveCurrent_pn3n3_c20260101__20260331_zJaVVf8HxB0l" title="Warranty reserve - current">102</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_ecustom--WarrantyReserveCurrent_pn3n3_c20250101__20250331_zYChDuW2Nqhi" title="Warranty reserve - current">526</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warranty reserve - noncurrent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_900_ecustom--WarrantyReserveNoncurrent_pn3n3_c20260101__20260331_zPGFKbzb98w8" title="Warranty reserve - noncurrent">139</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_ecustom--WarrantyReserveNoncurrent_pn3n3_c20250101__20250331_zjoYT7FbUzhk" title="Warranty reserve - noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0987">-</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 240000 692000 84000 83000 166000 241000 526000 102000 526000 139000 <p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zMeQDkTzPTkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b>Note 7 – <span id="xdx_823_zXmfJXCwQtL4">Leases </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company has an operating lease for its corporate headquarters and laboratory space, located in Sunnyvale, California, with an original lease period expiring June 30, 2024. In January 2024, the Company signed an addendum to the operating lease, extending the expiration of the lease through June 30, 2025. In March 2024, the Company signed an additional addendum to the operating lease, extending the expiration of the lease through December 31, 2025. In July 2024, the Company signed an additional addendum to the operating lease, extending the expiration of the lease through December 31, 2026. In April 2025, the Company signed an addendum to lease additional office space on a short-term basis in an adjacent office space. The Company accounted for the modification as a separate contract and will recognize associated lease payments in net loss over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In January 2025, the Company executed an operating lease for its new corporate headquarters, laboratory and manufacturing facility in Santa Clara, California. The term of the lease commenced on January 17, 2025, the date on which the landlord made the property available to the Company for the purpose of constructing leasehold improvements that will remain the property of the Company during lease term. As a result of entering into this lease agreement, the Company recorded a right-of-use asset and corresponding lease liability of $<span id="xdx_906_eus-gaap--OperatingLeaseLiability_iI_pn3n3_dm_c20250131_zSzdFrKybLCh" title="Operating lease liability">12.9</span> million, net of the tenant improvement allowance of $<span id="xdx_903_ecustom--TenantImprovementAllowance_iI_pn3n3_dm_c20250131_z0SBntE0qMRf" title="Tenant improvement allowance">4.1</span> million on the commencement date. Tenant improvement allowance was fully utilized as of March 31, 2026, of which, to date, the Company received reimbursements totaling $<span id="xdx_908_ecustom--ReimbursementsReceived_pn3n3_dm_c20260101__20260331_zVZfZIyXiWV9" title="Reimbursements received">1.5</span> million. The Company expects to receive additional reimbursements of $<span id="xdx_900_ecustom--AdditionalReimbursementsReceived_pn3n3_dm_c20260101__20260331_zMXJipSNMUo" title="Additional reimbursements received">2.6</span> million associated with this tenant improvement allowance, which were included in accounts and other receivables on the Company’s unaudited condensed consolidated balance sheets. Lease payments began in January 2026. The lease provides for a term of 132 months and includes an option to extend the lease for an additional five years, which was used in the calculation of the right of use asset and lease liability, as the Company is reasonably certain that the option will be exercised. The Company determined the probability of the exercise of a lease extension option based on its long-term strategic business outlook, significant leasehold improvements that are expected to have significant economic value to the Company, and costs relating to signing a new lease, among other factors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Amounts reported in the unaudited condensed consolidated balance sheets for operating leases in which the Company is the lessee as of March 31, 2026 and December 31, 2025, were as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"></span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfOperatingLeasesTableTextBlock_pn3n3_zjz66mzEnEIe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8B5_zczGQiNXOc3j" style="display: none">Schedule of operating leases</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Right of use operating lease asset</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20260331_zK5dAftYYC2" title="Right of use operating lease asset">12,263</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_907_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20251231_zP6ngEHH4KQb" title="Right of use operating lease asset">12,613</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Operating lease liability, current</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_c20260331_zI4JGT4IcwY7" title="Lease liability, current">1,097</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_906_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_c20251231_zGduTzs4wF8k" title="Lease liability, current">1,182</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Operating lease liability, noncurrent</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_c20260331_zlu3sWkyepQ1" title="Lease liability, noncurrent">17,397</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_c20251231_zPZCJfRNTer2" title="Lease liability, noncurrent">16,520</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Weighted-average remaining lease term</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span style="color: black"><span id="xdx_906_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20260331_zzpAmiTAgmha" title="Weighted-average remaining lease term">15.61</span> years</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20251231_zDbCkSdvkJr8" title="Weighted-average remaining lease term">15.71</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Weighted-average discount rate</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_901_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20260331_zY6e4Jt1GtW8" title="Weighted-average discount rate">6.36%</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20251231_z2T5VQbYXfe8" title="Weighted-average discount rate">6.40%</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zEptSuUwtGwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following table presents the components of lease costs in our unaudited condensed consolidated statements of operations for three months ended March 31, 2026 and 2025 (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_pn3n3_zxD5xn4VK2Xg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zwVDxQjz1Nkb" style="display: none">Schedule of lease costs</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20260101__20260331_zesZaD6Tv5Ug" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20250101__20250331_zNxt0s6B3pn8" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseCost_maOLEzs1V_zG8SnwsScYZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Operating lease costs</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">654</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">572</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--VariableLeaseCost_maOLEzs1V_z5gNqtwoAL09" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Variable lease costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">152</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShortTermLeaseCost_maOLEzs1V_zjGJQ4mZMfli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Short-term lease costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">29</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseExpense_iT_pn3n3_mtOLEzs1V_ziRdKglsId38" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 2.5pt">Total lease expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">835</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">614</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zivgygJdalt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Future lease payments for non-cancellable operating leases as of March 31, 2026, were as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNoncancellableOperatingLeasesTableTextBlock_pn3n3_zvgtAZhoPAZ6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BF_z36KxCbn2TAl" style="display: none">Schedule of non-cancellable operating leases</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_49F_20260331_zKKuanh7OBc4" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; white-space: nowrap">Years Ending December 31,</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzZml_zlHRvcoL9dZ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">2026 (remaining nine months)</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">918</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzZml_zZ00YnXbngTf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">936</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzZml_zYrZDjzcXyig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2028</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,294</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzZml_zjQbxRlkMfHi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,708</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzZml_zGv5XrhdLRNi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2030</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,791</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_maLOLLPzZml_z4MN3WmOaTU1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,838</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--UndiscountedLeasePayments_iTI_pn3n3_mtLOLLPzZml_z4J4A0larjZe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left">Total undiscounted lease payments</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">30,485</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zTCQiQWa4dK6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Less: effects of discounting</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,991</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zklTEYAaPoH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 18pt; text-align: left">Total operating lease liabilities</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,494</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zeWH3loe5XU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> 12900000 4100000 1500000 2600000 <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfOperatingLeasesTableTextBlock_pn3n3_zjz66mzEnEIe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8B5_zczGQiNXOc3j" style="display: none">Schedule of operating leases</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Right of use operating lease asset</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20260331_zK5dAftYYC2" title="Right of use operating lease asset">12,263</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_907_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20251231_zP6ngEHH4KQb" title="Right of use operating lease asset">12,613</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Operating lease liability, current</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_c20260331_zI4JGT4IcwY7" title="Lease liability, current">1,097</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_906_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_c20251231_zGduTzs4wF8k" title="Lease liability, current">1,182</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Operating lease liability, noncurrent</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_c20260331_zlu3sWkyepQ1" title="Lease liability, noncurrent">17,397</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_c20251231_zPZCJfRNTer2" title="Lease liability, noncurrent">16,520</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Weighted-average remaining lease term</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span style="color: black"><span id="xdx_906_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20260331_zzpAmiTAgmha" title="Weighted-average remaining lease term">15.61</span> years</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20251231_zDbCkSdvkJr8" title="Weighted-average remaining lease term">15.71</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Weighted-average discount rate</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_901_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20260331_zY6e4Jt1GtW8" title="Weighted-average discount rate">6.36%</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20251231_z2T5VQbYXfe8" title="Weighted-average discount rate">6.40%</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> </table> 12263000 12613000 1097000 1182000 17397000 16520000 P15Y7M9D P15Y8M15D 0.0636 0.0640 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_pn3n3_zxD5xn4VK2Xg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zwVDxQjz1Nkb" style="display: none">Schedule of lease costs</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20260101__20260331_zesZaD6Tv5Ug" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20250101__20250331_zNxt0s6B3pn8" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseCost_maOLEzs1V_zG8SnwsScYZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Operating lease costs</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">654</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">572</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--VariableLeaseCost_maOLEzs1V_z5gNqtwoAL09" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Variable lease costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">152</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShortTermLeaseCost_maOLEzs1V_zjGJQ4mZMfli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Short-term lease costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">29</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseExpense_iT_pn3n3_mtOLEzs1V_ziRdKglsId38" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left; padding-bottom: 2.5pt">Total lease expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">835</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">614</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 654000 572000 152000 33000 29000 9000 835000 614000 <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNoncancellableOperatingLeasesTableTextBlock_pn3n3_zvgtAZhoPAZ6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BF_z36KxCbn2TAl" style="display: none">Schedule of non-cancellable operating leases</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_49F_20260331_zKKuanh7OBc4" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; white-space: nowrap">Years Ending December 31,</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzZml_zlHRvcoL9dZ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">2026 (remaining nine months)</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">918</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzZml_zZ00YnXbngTf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">936</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzZml_zYrZDjzcXyig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2028</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,294</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzZml_zjQbxRlkMfHi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,708</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzZml_zGv5XrhdLRNi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2030</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,791</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_maLOLLPzZml_z4MN3WmOaTU1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,838</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--UndiscountedLeasePayments_iTI_pn3n3_mtLOLLPzZml_z4J4A0larjZe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left">Total undiscounted lease payments</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">30,485</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zTCQiQWa4dK6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Less: effects of discounting</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,991</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zklTEYAaPoH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 18pt; text-align: left">Total operating lease liabilities</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,494</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 918000 936000 1294000 1708000 1791000 23838000 30485000 11991000 18494000 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zLE7iPolw5Ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b>Note 8 - <span id="xdx_82F_z3el1Jiz8I9">Notes payable </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">At March 31, 2026 and December 31, 2025, notes payable consisted of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDebtTableTextBlock_pn3n3_zGGC4SL302H2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes payable (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; color: black; text-align: justify; text-indent: 18pt"><span id="xdx_8B2_z3dUIRZyFYmf" style="display: none">Schedule of notes payable</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td id="xdx_49F_20260331_z3QHtE6JOjBb" style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td id="xdx_49F_20251231_ztnFCRAOWhq3" style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayableCurrentAbstract_iB_zIuZk8dRiZ1a" style="vertical-align: bottom"> <td style="white-space: nowrap; color: black; text-align: justify">Notes payable, current</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NotesPayableCurrent_i01I_pn3n3_maNPzuEU_zvchH5KvVT88" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: justify; text-indent: 18pt">Current portion of notes payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--LongtermNotesPayableCurrentAndNoncurrentAbstract_iB_zt4Cur5hi6Q3" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: justify">Notes payable, noncurrent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--NotesPayableGross_i01I_pn3n3_maLTNPzNbL_zraSmDdfSMgf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: justify; text-indent: 18pt">Long-term portion of notes payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">41,800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">41,800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--UnamortizedDeferredLoanCosts_i01NI_pn3n3_di_msLTNPzNbL_zcFX3CJ69aL6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; color: black; text-align: justify; text-indent: 18pt">Less: unamortized deferred loan costs</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right">(258</td><td style="white-space: nowrap; color: black; text-align: left">)</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right">(311</td><td style="white-space: nowrap; color: black; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountNoncurrent_i01NI_pn3n3_di_msLTNPzNbL_z42iP0m8FL8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: justify; padding-bottom: 1pt; text-indent: 18pt">Less: unamortized discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(502</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(603</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--LongTermNotesPayable_i01TI_pn3n3_mtLTNPzNbL_maNPzuEU_zw7DFSpHuxoe" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: justify; padding-bottom: 1pt">Notes payable, noncurrent, net</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right">41,040</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right">40,886</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayable_iTI_pn3n3_mtNPzuEU_zB2BWcCZu4j2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: justify; padding-bottom: 2.5pt">Total notes payable, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41,040</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,886</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zyhgdb4rzfO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The following table presents information regarding the Company’s notes payable principal repayment obligations as of March 31, 2026 (in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_pn3n3_zdzP8NTYBjXe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes payable (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 18pt; text-align: left"><span id="xdx_8B9_zokSERlWbzK6" style="display: none">Schedule of maturities notes payable</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20260331_zYvgrV4Gd7O" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; white-space: nowrap">Years Ended December 31,</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDzz7k_zIQ2KwK6EvIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; white-space: nowrap">2026</td><td> </td><td> </td> <td style="white-space: nowrap; text-align: left">$</td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDzz7k_zSaydSX2gnvf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 18pt; width: 81%; text-align: left">2027</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 15%; text-align: right">41,800</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDzz7k_zBpQhWlqbOP1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total minimum payments</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41,800</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z1mgjF8O6wq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b><i>Runway Growth Finance Corp </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On June 30, 2022, the Company entered into a loan and security agreement with Runway Growth Finance Corp. The debt is secured against substantially all assets of the Company, except for the Company’s intellectual property but includes all proceeds from the sale of intellectual property. As of March 31, 2026 and December 31, 2025, the outstanding principal balance was $<span id="xdx_90C_ecustom--NotesPayableGross_iI_pn3n3_dm_c20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zYcNAwEZazG1" title="Outstanding principal amount">41.8</span> million and $<span id="xdx_90F_ecustom--NotesPayableGross_iI_pn3n3_dm_c20251231__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zACKr7aKjOk7" title="Outstanding principal amount">41.8</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Interest on the term loan accrues on the principal amount outstanding at a floating per annum rate equal to the greater of the rate of interest noted in The Wall Street Journal Money Rates section, as the “Prime Rate” or 4.00% plus a margin of 4.9% and is payable monthly in arrears and shall be computed on the basis of a 360-day year for the actual number of days elapsed. The Company is required to make interest only payments from July 2022 to May 2027. The note payable has a maturity date of <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20260101__20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zZJrBexRWyfa" title="Maturity date">June 15, 2027</span>, at which time any unpaid interest, outstanding principal balance, and a final payment of 4.5% of the original principal amount borrowed shall be due in full. If the Company repays the loan prior to maturity, the Company will be required to pay a prepayment fee of 0.5% of the outstanding principal balance. The Company is also required to pay a 3% success fee of the funded principal amount of the term loan at the time of a liquidity event, as defined in the loan and security agreement. The success fee is enforceable within 10 years from the execution date of the agreement. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company has accounted for the final payment of $<span id="xdx_90D_eus-gaap--RepaymentsOfNotesPayable_pn3n3_dm_c20260101__20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zUFSq6Zyr9Wh" title="Debt payment">1.8</span> million as a discount of the note that will be amortized over the life of the loan using the effective interest method. Amortization of the discount was $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_dm_c20260101__20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zhxXnx1laD1k" title="Amortization of debt discount">0.1</span> million and $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_dm_c20250101__20250331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zdPU9gGD8wl8" title="Amortization of debt discount">0.1</span> million for the three-month period ended March 31, 2026 and 2025, respectively. This amount was recorded as additional interest expense in the accompanying unaudited condensed consolidated statements of operations. As of March 31, 2026 and December 31, 2025, the note has been shown net of unamortized discounts of $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_dm_c20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zY8XNFkkg00e" title="Unamortized debt discounts">0.5</span> million and $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_dm_c20251231__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zc0ekF4mpFJi" title="Unamortized debt discounts">0.6</span> million, respectively. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company incurred loan costs of $<span id="xdx_90D_eus-gaap--PaymentsOfLoanCosts_pn3n3_dm_c20260101__20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_z2t7bo0Lvyoi" title="Loan costs">1.0</span> million, which are being amortized over the life of the loan using the effective interest method. Amortization of loan costs was $<span id="xdx_90D_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dm_c20260101__20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zRaGLLozvSJe" title="Amortization of loan costs">0.1</span> million and $<span id="xdx_901_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dm_c20250101__20250331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zKirY8o56aN1" title="Amortization of loan costs">0.1</span> million for the three-month period ended March 31, 2026 and 2025, respectively. As of March 31, 2026 and December 31, 2025, the note has been shown net of unamortized loan costs of $<span id="xdx_904_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_dm_c20260331__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zU8VNTyXvWBb" title="Unamortized loan costs">0.3</span> million and $<span id="xdx_90B_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_dm_c20251231__dei--LegalEntityAxis__custom--RunwayGrowthFinanceCorpMember_zXtseEfCHtq9" title="Unamortized loan costs">0.3</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company is subject to customary financial and reporting covenants under the loan and security agreement. As of March 31, 2026 and December 31, 2025, the Company was in compliance with all debt covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDebtTableTextBlock_pn3n3_zGGC4SL302H2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes payable (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; color: black; text-align: justify; text-indent: 18pt"><span id="xdx_8B2_z3dUIRZyFYmf" style="display: none">Schedule of notes payable</span></td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td id="xdx_49F_20260331_z3QHtE6JOjBb" style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td id="xdx_49F_20251231_ztnFCRAOWhq3" style="color: black; text-align: right"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayableCurrentAbstract_iB_zIuZk8dRiZ1a" style="vertical-align: bottom"> <td style="white-space: nowrap; color: black; text-align: justify">Notes payable, current</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NotesPayableCurrent_i01I_pn3n3_maNPzuEU_zvchH5KvVT88" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: justify; text-indent: 18pt">Current portion of notes payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--LongtermNotesPayableCurrentAndNoncurrentAbstract_iB_zt4Cur5hi6Q3" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: justify">Notes payable, noncurrent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--NotesPayableGross_i01I_pn3n3_maLTNPzNbL_zraSmDdfSMgf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: justify; text-indent: 18pt">Long-term portion of notes payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">41,800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">41,800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--UnamortizedDeferredLoanCosts_i01NI_pn3n3_di_msLTNPzNbL_zcFX3CJ69aL6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; color: black; text-align: justify; text-indent: 18pt">Less: unamortized deferred loan costs</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right">(258</td><td style="white-space: nowrap; color: black; text-align: left">)</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right">(311</td><td style="white-space: nowrap; color: black; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountNoncurrent_i01NI_pn3n3_di_msLTNPzNbL_z42iP0m8FL8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: justify; padding-bottom: 1pt; text-indent: 18pt">Less: unamortized discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(502</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(603</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--LongTermNotesPayable_i01TI_pn3n3_mtLTNPzNbL_maNPzuEU_zw7DFSpHuxoe" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: justify; padding-bottom: 1pt">Notes payable, noncurrent, net</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right">41,040</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right">40,886</td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayable_iTI_pn3n3_mtNPzuEU_zB2BWcCZu4j2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: justify; padding-bottom: 2.5pt">Total notes payable, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41,040</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,886</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 41800000 41800000 258000 311000 502000 603000 41040000 40886000 41040000 40886000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_pn3n3_zdzP8NTYBjXe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes payable (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 18pt; text-align: left"><span id="xdx_8B9_zokSERlWbzK6" style="display: none">Schedule of maturities notes payable</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20260331_zYvgrV4Gd7O" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; white-space: nowrap">Years Ended December 31,</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDzz7k_zIQ2KwK6EvIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; text-align: left; white-space: nowrap">2026</td><td> </td><td> </td> <td style="white-space: nowrap; text-align: left">$</td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDzz7k_zSaydSX2gnvf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 18pt; width: 81%; text-align: left">2027</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 15%; text-align: right">41,800</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDzz7k_zBpQhWlqbOP1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total minimum payments</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41,800</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 41800000 41800000 41800000 41800000 2027-06-15 1800000 100000 100000 500000 600000 1000000.0 100000 100000 300000 300000 <p id="xdx_80D_ecustom--ConvertiblePreferredStockTextBlock_zjD8ydilh3Nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 9 - <span id="xdx_82E_zYP6aQZHF30c">Convertible preferred stock</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">As of March 31, 2026 and December 31, 2025, <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_z2rqGs1Rghge" title="Preferred stock, shares authorized"><span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_znK7iRvWvAg6" title="Preferred stock, shares authorized">10,000,000</span></span> shares of convertible preferred stock were authorized, of which <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zTza02hecav5" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zRBKaQd1HTPi" title="Preferred stock, shares outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zh38j9cisE26" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_z6BbVBNUuIn6" title="Preferred stock, shares outstanding">no</span></span></span></span> shares were issued or outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 10000000 10000000 0 0 0 0 <p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zcD6Zzr62xW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 10 - <span id="xdx_82B_zLz9Wv2drjPh">Common stock</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company’s board of directors. As of March 31, 2026 and December 31, 2025, <span id="xdx_903_eus-gaap--DividendsCommonStock_pn3n3_do_c20260101__20260331_z88yM7pFOUoh" title="Dividends"><span id="xdx_90A_eus-gaap--DividendsCommonStock_pn3n3_do_c20250101__20251231_zRA5eVKQdWD4" title="Dividends">no</span></span> dividends have been declared.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026 and December 31, 2025, <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20260331_zfo3m1tdUTBk" title="Common stock, shares authorized"><span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20251231_zcbSxMn4gAc6" title="Common stock, shares authorized">600,000,000</span></span> shares were authorized, of which <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20260331_zmiwzjKvESV2" title="Common stock, shares outstanding">45,055,736</span> shares and <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20251231_z0kOEgxF3TF4" title="Common stock, shares outstanding">45,025,917</span> shares, respectively, were outstanding. See Note 1, “Business and organization – <i>Reverse stock split</i>” for additional information regarding the Reverse Stock Split that was effective April 1, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company completed its initial public offering and began trading on the ASX on November 24, 2021, under the symbol “EBR”. The ASX uses a Clearing House Electronic Subregister System (“CHESS”) for the clearance and settlement of trades on the ASX. The State of Delaware does not recognize the CHESS system of holding securities or electronic transfers of legal title to shares. To enable companies to have their securities cleared and settled electronically through CHESS, CDIs are issued. CDIs are units of beneficial ownership in shares and are traded in a manner similar to shares of Australian companies listed on the ASX. The legal title to the shares are held by a depository, CHESS Depositary Nominees (“CDN’), which is a wholly owned subsidiary of the ASX, and is an approved general participant of ASX Settlement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, the Company has reserved the following shares of common stock for issuance as of March 31, 2026<span style="background-color: white">: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfCommonStockTableTextBlock_pn3n3_zPMZ0b5xMHV5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Common stock (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B8_zAyOkzsvprQ5" style="display: none">Schedule of common stock</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Common stock warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--CommonStockWarrantsMember_zwuY3FpewpMg" title="Total shares of common stock reserved for issuance">1,947,853</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2013 Equity Incentive Plan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--N2013EquityIncentivePlanMember_zxw2tu1F1Jq4" title="Total shares of common stock reserved for issuance">1,611,890</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021 Equity Incentive Plan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--N2021EquityIncentivePlanMember_zifbjNq5qC0g" title="Total shares of common stock reserved for issuance">3,673,015</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Outside of 2021 Equity Incentive Plan</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--OutsideOf2021EquityIncentivePlanMember_zzp68GWeuiY2" title="Total shares of common stock reserved for issuance">89,758</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total shares of common stock reserved for issuance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331_znQ9XnSldXK" title="Total shares of common stock reserved for issuance">7,322,516</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 0 0 600000000 600000000 45055736 45025917 <table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfCommonStockTableTextBlock_pn3n3_zPMZ0b5xMHV5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Common stock (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B8_zAyOkzsvprQ5" style="display: none">Schedule of common stock</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Common stock warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--CommonStockWarrantsMember_zwuY3FpewpMg" title="Total shares of common stock reserved for issuance">1,947,853</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2013 Equity Incentive Plan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--N2013EquityIncentivePlanMember_zxw2tu1F1Jq4" title="Total shares of common stock reserved for issuance">1,611,890</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021 Equity Incentive Plan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--N2021EquityIncentivePlanMember_zifbjNq5qC0g" title="Total shares of common stock reserved for issuance">3,673,015</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Outside of 2021 Equity Incentive Plan</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--OutsideOf2021EquityIncentivePlanMember_zzp68GWeuiY2" title="Total shares of common stock reserved for issuance">89,758</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total shares of common stock reserved for issuance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331_znQ9XnSldXK" title="Total shares of common stock reserved for issuance">7,322,516</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1947853 1611890 3673015 89758 7322516 <p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHbGGMqeonu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 11 - <span id="xdx_828_zb3gWZQwWA8e">Stock-based compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company and its stockholders adopted the 2013 Equity Incentive Plan (the “2013 Plan”) June 18, 2013, which reserved shares of the Company’s common stock for the granting of incentive and nonqualified stock options to employees, directors, and consultants. On October 14, 2021, the Company replaced the 2013 Plan with the 2021 Equity Incentive Plan (the “2021 Plan”) in connection with its initial public offering. Under the 2021 Plan, <span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20211014__us-gaap--PlanNameAxis__custom--Plan2021Member_zDSg7XL7L56" title="Common stock reserved">3,673,015</span> shares of common stock are reserved. The Company may grant options to purchase common stock, stock appreciation rights, restricted stock awards and other forms of stock-based compensation. Stock options generally vest over four years and expire no later than 10 years from the date of grant. The Board of Directors has the authority to select the employees to whom options are granted and determine the terms of each option, including: i) the number of shares of common stock subject to the option; ii) when the option becomes exercisable; iii) the option exercise price, which must be at least 100% of the fair market value of the common stock as of the date of grant; and iv) the duration of the option, which may not exceed 10 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026, options to purchase a total of <span id="xdx_90C_eus-gaap--SharesOutstanding_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--Plan2021Member_zMKrgAmNEn67" title="Remained shares outstanding">3,100,009</span> shares of common stock remained outstanding and <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--Plan2021Member_zADAVFJAozUd" title="Shares available for grant">573,006</span> shares remain available for grant under the 2021 Plan and <span id="xdx_900_eus-gaap--SharesOutstanding_iI_pid_c20260331__us-gaap--PlanNameAxis__custom--Plan2021Member_zQtIC3432Cq9" title="Remained shares outstanding">89,758</span> remained outstanding outside of the 2021 Plan. As of March 31, 2026, options to purchase a total of <span id="xdx_907_eus-gaap--SharesOutstanding_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--Plan2013Member_z6ZxXxXWfeW8" title="Remained shares outstanding">1,611,890</span> shares of common stock remained outstanding under the 2013 Plan. As of March 31, 2026, <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_do_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--Plan2013Member_z1qH7hKRmZ6" title="Shares available for grant">no</span> shares of common stock remain available for grant under the 2013 Plan. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Stock option activity for the three-month period ended March 31, 2026, was as follows:</span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_zgVz3z4TKbKk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based compensation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8BE_zIpyeXLJaix3" style="display: none">Schedule of stock option activity</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Shares</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Weighted-<br/> Average <br/> Exercise <br/> Price</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Weighted-<br/> Average <br/> Remaining <br/> Contractual <br/> Life (in years)</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; color: black; text-align: left"><span style="color: black">Outstanding as of December 31, 2025</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zIu5R5ufIRSi" title="Shares outstanding at begining">4,810,761</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztdzgpDnPEad" title="Weighted average exercise price at begining">4.91</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 12%; color: black; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zetsqO1wugaa" title="Weighted-average remaining contractual life">6.76</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZ6iH6aaK1g9" title="Shares, granted">64,400</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zT2kut9BKwrh" title="Weighted average exercise price, granted">5.13</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left"><span style="color: black">Cancelled</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQOvzhGW8ek9" title="Shares, cancelled">(44,931</span></td><td style="white-space: nowrap; color: black; text-align: left">)</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zv8MsOhtzvD7" title="Weighted Average Exercise Price, cancelled">6.37</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Exercised</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1X9GYvZnfh9" title="Shares, exercised">(28,573</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVbHji2K257d" title="Weighted Average Exercise Price, exercised">4.62</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; color: black; text-align: left"><span style="color: black">Outstanding as of March 31, 2026</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztFQ26OIKwx1" title="Shares outstanding at ending">4,801,657</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjoKJQ0p9nF2" title="Weighted average exercise price at ending">4.91</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zgiUmFLSga8e" title="Weighted-average remaining contractual life">6.54</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left"><span style="color: black">Vested and expected to vest as of March 31, 2026</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znHiLPMwO987" title="Shares vested and expected to vest">4,801,657</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left">$</td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqnQnqKZyfjd" title="Weighted-average exercise price, vested and expected to vest">4.91</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJ4IgpgSCjqf" title="Weighted-average remaining contractual life (in years), vested and expected to vest">6.54</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Exercisable as of March 31, 2026</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zLKCi6NWx1Ne" title="Shares, exercisable">3,225,978</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zghRT0Fdb8ug" title="Weighted average exercise price, exercisable">3.83</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zOmPkHVukfQi" title="Weighted-average remaining contractual life (in years), exercisable">5.48</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zmKV2kBBfYHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The fair value of the options granted to employees is estimated on the grant date using the Black-Scholes option valuation model. This valuation model for stock-based compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted-average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock, an assumed risk-free interest rate and expected dividends. The Company uses the simplified calculation of expected life and volatility is derived from the combination of the average historical stock volatilities of several publicly traded companies with characteristics similar to those of the Company, and on the Company’s stock price, as quoted on the ASX. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. The Company uses the straight-line method for expense attribution. The weighted-average grant-date fair values of stock options granted during the three months ended March 31, 2026 and 2025, was $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z7EhizXvO1n4" title="Weighted-average grant-date fair values">3.23</span> per share and $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20250101__20250331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zKeCHM4XPGE8" title="Weighted-average grant-date fair values">6.38</span> per share, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The following assumptions were used to calculate the grant-date fair value of employee stock options granted during the three months ended March 31, 2026 and 2025:</span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_pn3n3_zxjGENeluNSe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based compensation (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8BB_z0H8vS3Pael1" style="display: none">Schedule of assumptions used</span></td><td style="color: black"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td><td> </td><td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Expected term (in years)</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260331_z5B7jsLaJutc" title="Expected term (in years)">6.08</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black"> </td> <td style="color: black; text-align: right; width: 15%"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_zU663mMjn7I7" title="Expected term (in years)">5.53</span> – <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_zRhONzzfBhRf" title="Expected term (in years)">6.08</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Expected volatility</td><td style="color: black"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="color: black"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_z97ECXo5sZF7" title="Expected volatility">65.31%</span> - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_z93lr2YcpL33" title="Expected volatility">65.50%</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td><td></td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_zjOlU9hUsgwa" title="Expected volatility">65.27%</span> - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_zajamO5q3N2" title="Expected volatility">65.73%</span></td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Expected dividend yield</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20260101__20260331_zngt7o9lzhSg" title="Expected dividend yield">0.00%</span></td><td style="white-space: nowrap; color: black; text-align: left"></td><td style="color: black"> </td> <td style="color: black"> </td> <td style="color: black; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20250101__20250331_z8eJU8whTkOd" title="Expected dividend yield">0.00%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Risk-free interest rate</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span style="color: black"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_zguMJW2DeU0d" title="Risk-free interest rate">3.72%</span> - <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_z0vh8b3NSALa" title="Risk-free interest rate">4.11%</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black"> </td> <td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_zt9Id8fUWR35" title="Risk-free interest rate">4.09%</span> - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_zTkWiVYZirug" title="Risk-free interest rate">4.47%</span></td> <td> </td></tr> </table> <p id="xdx_8AC_z5LjNEpUTxT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The following table presents classification of stock-based compensation expense within the </span>accompanying unaudited condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 <span style="background-color: white">(in thousands): </span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_pn3n3_z2gvlB5KpfQc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based compensation (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8B4_zavBLCfnfxib" style="display: none">Schedule of stock-based compensation expense</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Cost of goods sold</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--CostOfGoodsMember_zT4BGFyrBq3g" title="Stock-based compensation expense">36</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--CostOfGoodsMember_zQMQnaFvXp5" title="Stock-based compensation expense"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentMember_zjljs3E34j0h" title="Stock-based compensation expense">275</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentMember_z7mG6bTQNjb7" title="Stock-based compensation expense">244</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 1pt">General and administrative</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zaunjS884NBc" title="Stock-based compensation expense">596</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zJAb9F2ZjW3i" title="Stock-based compensation expense">261</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; padding-bottom: 2.5pt; text-indent: 18pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331_zvwdofW5q219" title="Stock-based compensation expense">907</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331_zBQ7negMlzHe" title="Stock-based compensation expense">505</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zRd6DJ26BX7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026, there was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn3n3_dm_c20260331__us-gaap--AwardTypeAxis__custom--UnvestedStockOptionsMember_z6xUWkXPDuxc" title="Unamortized stock-based compensation cost">8.7</span> million of unamortized stock-based compensation cost, related to unvested stock options which is expected to be recognized over a weighted-average period of <span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--UnvestedStockOptionsMember_zu430CuYPB57" title="Weighted average period">2.58</span> years. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 3673015 3100009 573006 89758 1611890 0 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_zgVz3z4TKbKk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based compensation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left"><span id="xdx_8BE_zIpyeXLJaix3" style="display: none">Schedule of stock option activity</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black; text-align: left"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Shares</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Weighted-<br/> Average <br/> Exercise <br/> Price</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center"><span style="color: black">Weighted-<br/> Average <br/> Remaining <br/> Contractual <br/> Life (in years)</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; color: black; text-align: left"><span style="color: black">Outstanding as of December 31, 2025</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 12%; color: black; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zIu5R5ufIRSi" title="Shares outstanding at begining">4,810,761</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 12%; color: black; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztdzgpDnPEad" title="Weighted average exercise price at begining">4.91</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 12%; color: black; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zetsqO1wugaa" title="Weighted-average remaining contractual life">6.76</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZ6iH6aaK1g9" title="Shares, granted">64,400</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zT2kut9BKwrh" title="Weighted average exercise price, granted">5.13</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; color: black; text-align: left"><span style="color: black">Cancelled</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQOvzhGW8ek9" title="Shares, cancelled">(44,931</span></td><td style="white-space: nowrap; color: black; text-align: left">)</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zv8MsOhtzvD7" title="Weighted Average Exercise Price, cancelled">6.37</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18pt; text-align: left">Exercised</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1X9GYvZnfh9" title="Shares, exercised">(28,573</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVbHji2K257d" title="Weighted Average Exercise Price, exercised">4.62</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; color: black; text-align: left"><span style="color: black">Outstanding as of March 31, 2026</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztFQ26OIKwx1" title="Shares outstanding at ending">4,801,657</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjoKJQ0p9nF2" title="Weighted average exercise price at ending">4.91</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zgiUmFLSga8e" title="Weighted-average remaining contractual life">6.54</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left"><span style="color: black">Vested and expected to vest as of March 31, 2026</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znHiLPMwO987" title="Shares vested and expected to vest">4,801,657</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left">$</td><td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqnQnqKZyfjd" title="Weighted-average exercise price, vested and expected to vest">4.91</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJ4IgpgSCjqf" title="Weighted-average remaining contractual life (in years), vested and expected to vest">6.54</span></td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Exercisable as of March 31, 2026</td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zLKCi6NWx1Ne" title="Shares, exercisable">3,225,978</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zghRT0Fdb8ug" title="Weighted average exercise price, exercisable">3.83</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zOmPkHVukfQi" title="Weighted-average remaining contractual life (in years), exercisable">5.48</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 4810761 4.91 P6Y9M3D 64400 5.13 44931 6.37 28573 4.62 4801657 4.91 P6Y6M14D 4801657 4.91 P6Y6M14D 3225978 3.83 P5Y5M23D 3.23 6.38 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_pn3n3_zxjGENeluNSe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based compensation (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8BB_z0H8vS3Pael1" style="display: none">Schedule of assumptions used</span></td><td style="color: black"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td><td> </td><td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Expected term (in years)</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260331_z5B7jsLaJutc" title="Expected term (in years)">6.08</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black"> </td> <td style="color: black; text-align: right; width: 15%"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_zU663mMjn7I7" title="Expected term (in years)">5.53</span> – <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_zRhONzzfBhRf" title="Expected term (in years)">6.08</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Expected volatility</td><td style="color: black"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="color: black"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_z97ECXo5sZF7" title="Expected volatility">65.31%</span> - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_z93lr2YcpL33" title="Expected volatility">65.50%</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td><td></td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_zjOlU9hUsgwa" title="Expected volatility">65.27%</span> - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_zajamO5q3N2" title="Expected volatility">65.73%</span></td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Expected dividend yield</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20260101__20260331_zngt7o9lzhSg" title="Expected dividend yield">0.00%</span></td><td style="white-space: nowrap; color: black; text-align: left"></td><td style="color: black"> </td> <td style="color: black"> </td> <td style="color: black; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20250101__20250331_z8eJU8whTkOd" title="Expected dividend yield">0.00%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Risk-free interest rate</td><td style="color: black"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"><span style="color: black"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_zguMJW2DeU0d" title="Risk-free interest rate">3.72%</span> - <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_z0vh8b3NSALa" title="Risk-free interest rate">4.11%</span></span></td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="color: black"> </td> <td style="color: black"> </td> <td style="color: black; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_zt9Id8fUWR35" title="Risk-free interest rate">4.09%</span> - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_zTkWiVYZirug" title="Risk-free interest rate">4.47%</span></td> <td> </td></tr> </table> P6Y29D P5Y6M10D P6Y29D 0.6531 0.6550 0.6527 0.6573 0.0000 0.0000 0.0372 0.0411 0.0409 0.0447 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_pn3n3_z2gvlB5KpfQc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based compensation (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left"><span id="xdx_8B4_zavBLCfnfxib" style="display: none">Schedule of stock-based compensation expense</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Cost of goods sold</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--CostOfGoodsMember_zT4BGFyrBq3g" title="Stock-based compensation expense">36</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 15%; color: black; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--CostOfGoodsMember_zQMQnaFvXp5" title="Stock-based compensation expense"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentMember_zjljs3E34j0h" title="Stock-based compensation expense">275</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentMember_z7mG6bTQNjb7" title="Stock-based compensation expense">244</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left; padding-bottom: 1pt">General and administrative</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zaunjS884NBc" title="Stock-based compensation expense">596</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zJAb9F2ZjW3i" title="Stock-based compensation expense">261</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; padding-bottom: 2.5pt; text-indent: 18pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensation_pn3n3_c20260101__20260331_zvwdofW5q219" title="Stock-based compensation expense">907</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensation_pn3n3_c20250101__20250331_zBQ7negMlzHe" title="Stock-based compensation expense">505</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 36000 275000 244000 596000 261000 907000 505000 8700000 P2Y6M29D <p id="xdx_803_eus-gaap--ProductWarrantyDisclosureTextBlock_zKwtcrsUJfM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 12 - <span id="xdx_828_zVsPhBp3urxl">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following warrants were outstanding as of March 31, 2026 and December 31, 2025:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--ScheduleOfWarrantsOutstandingTableTextBlock_pn3n3_zH4WPAIpPe3b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Warrants (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B0_zSuQAxFY6pLk" style="display: none">Schedule of warrants were outstanding</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Shares of Common Stock Issuable <br/>for Outstanding Warrants as of</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Warrant Issuance</td><td style="white-space: nowrap; text-align: left"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">March 31, <br/> 2026</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">December 31,<br/>2025</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Exercise<br/> Price</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Expiration<br/> Date</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span id="xdx_900_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_z1WLVasb2zva" title="Warrant issuance date">June 30, 2016</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zk21tHiXmmG3" title="Shares of common stock issuable for outstanding warrants">3,639</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zAIpPWsUulqb" title="Shares of common stock issuable for outstanding warrants">3,639</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zW4Wv70TdTs8" title="Exercise price">8.20</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zayLu7mbeoB2" title="Expiration date">June 30, 2026</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_907_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zd4SQ4WDSFz8" title="Warrant issuance date">October 30, 2017</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zqJNdKmThMCj" title="Shares of common stock issuable for outstanding warrants">195,061</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zANkDrdiaHyb" title="Shares of common stock issuable for outstanding warrants">195,061</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_z7R3H2StEUX3" title="Exercise price">4.10</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zlkxaUKFpXae" title="Expiration date">October 29, 2027</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_909_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zcCyo3D8SOv9" title="Warrant issuance date">February 28, 2018</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zkm6KeLpbrsi" title="Shares of common stock issuable for outstanding warrants">23,418</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zZCbbWU0YPK2" title="Shares of common stock issuable for outstanding warrants">23,418</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zLFVKjIm1KEb" title="Exercise price">8.20</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zdqfs7Bca0Xi" title="Expiration date">February 28, 2028</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90B_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zRxBOMcWKtW7" title="Warrant issuance date">August 26, 2019</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zU4JIrJ1UsT4" title="Shares of common stock issuable for outstanding warrants">443,790</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zKZReaDiV5t7" title="Shares of common stock issuable for outstanding warrants">443,790</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zrRiS92ho5v4" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_z6vl2eRinFi5" title="Expiration date">August 26, 2029</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_90F_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zFqOXxyvgy48" title="Warrant issuance date">March 13, 2020</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zs8IoFu3QOCb" title="Shares of common stock issuable for outstanding warrants">442,294</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zW1IFR352cS4" title="Shares of common stock issuable for outstanding warrants">442,294</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zo1cYZ8tFqm2" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zqYpltLbZrW6" title="Expiration date">March 13, 2030</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_907_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zrr1CYyjs48c" title="Warrant issuance date">March 25, 2020</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zmDfvAZpdHVa" title="Shares of common stock issuable for outstanding warrants">44,150</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zo9XEW7xBdAb" title="Shares of common stock issuable for outstanding warrants">44,150</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_z35W6csCZRa6" title="Exercise price">1.40</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zlyawo2OwiDf" title="Expiration date">March 24, 2030</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_909_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zXzAgLSz1aD4" title="Warrant issuance date">February 12, 2021</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zVqNjqSDXPCd" title="Shares of common stock issuable for outstanding warrants">173,205</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zBtMBYcZJTwe" title="Shares of common stock issuable for outstanding warrants">173,205</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zCcHhVEG3fHa" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_z6jT4Z2nuEU2" title="Expiration date">February 12, 2031</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_905_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_z6E8aN5RIYnh" title="Warrant issuance date">June 25, 2021</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zBhDLVtH3RSb" title="Shares of common stock issuable for outstanding warrants">288,721</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zBUg7OgpAR05" title="Shares of common stock issuable for outstanding warrants">288,721</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zf1z2hPu8wB3" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zzcxZV72AXuk" title="Expiration date">June 25, 2031</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_901_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zlS939ABfTo5" title="Warrant issuance date">August 16, 2021</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zBkk089qalhg" title="Shares of common stock issuable for outstanding warrants">22,427</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_z3NVhsTGN517" title="Shares of common stock issuable for outstanding warrants">22,427</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zi6he07btIlf" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zBUPCm98tMvg" title="Expiration date">June 25, 2031</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90B_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_z0fkzA7Yrkcj" title="Warrant issuance date">October 4, 2021</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_zg9NUDk1vpVl" title="Shares of common stock issuable for outstanding warrants">311,148</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_zPs59ZRMOWK8" title="Shares of common stock issuable for outstanding warrants">311,148</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_zLnAB7p40uac" title="Exercise price">5.90</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_z0Zx2MOEXl02" title="Expiration date">October 4, 2031</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt; text-indent: 18pt">Total</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zr6cmtdFzdc1" title="Shares of common stock issuable for outstanding warrants">1,947,853</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDm0KSgDlYVh" title="Shares of common stock issuable for outstanding warrants">1,947,853</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026, the weighted-average exercise price of outstanding warrants was $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDe3yfqS1Xk4" title="Weighted-average exercise price of outstanding warrants">5.64</span>, with a weighted-average remaining contractual life of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXcOzEsp7NE1" title="Weighted-average remaining contractual life">4.09</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--ScheduleOfWarrantsOutstandingTableTextBlock_pn3n3_zH4WPAIpPe3b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Warrants (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B0_zSuQAxFY6pLk" style="display: none">Schedule of warrants were outstanding</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Shares of Common Stock Issuable <br/>for Outstanding Warrants as of</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Warrant Issuance</td><td style="white-space: nowrap; text-align: left"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">March 31, <br/> 2026</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">December 31,<br/>2025</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Exercise<br/> Price</td><td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Expiration<br/> Date</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span id="xdx_900_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_z1WLVasb2zva" title="Warrant issuance date">June 30, 2016</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zk21tHiXmmG3" title="Shares of common stock issuable for outstanding warrants">3,639</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zAIpPWsUulqb" title="Shares of common stock issuable for outstanding warrants">3,639</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zW4Wv70TdTs8" title="Exercise price">8.20</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June302016Member_zayLu7mbeoB2" title="Expiration date">June 30, 2026</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_907_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zd4SQ4WDSFz8" title="Warrant issuance date">October 30, 2017</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zqJNdKmThMCj" title="Shares of common stock issuable for outstanding warrants">195,061</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zANkDrdiaHyb" title="Shares of common stock issuable for outstanding warrants">195,061</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_z7R3H2StEUX3" title="Exercise price">4.10</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October302017Member_zlkxaUKFpXae" title="Expiration date">October 29, 2027</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_909_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zcCyo3D8SOv9" title="Warrant issuance date">February 28, 2018</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zkm6KeLpbrsi" title="Shares of common stock issuable for outstanding warrants">23,418</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zZCbbWU0YPK2" title="Shares of common stock issuable for outstanding warrants">23,418</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zLFVKjIm1KEb" title="Exercise price">8.20</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February282018Member_zdqfs7Bca0Xi" title="Expiration date">February 28, 2028</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90B_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zRxBOMcWKtW7" title="Warrant issuance date">August 26, 2019</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zU4JIrJ1UsT4" title="Shares of common stock issuable for outstanding warrants">443,790</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zKZReaDiV5t7" title="Shares of common stock issuable for outstanding warrants">443,790</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_zrRiS92ho5v4" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August262019Member_z6vl2eRinFi5" title="Expiration date">August 26, 2029</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_90F_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zFqOXxyvgy48" title="Warrant issuance date">March 13, 2020</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zs8IoFu3QOCb" title="Shares of common stock issuable for outstanding warrants">442,294</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zW1IFR352cS4" title="Shares of common stock issuable for outstanding warrants">442,294</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zo1cYZ8tFqm2" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March132020Member_zqYpltLbZrW6" title="Expiration date">March 13, 2030</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_907_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zrr1CYyjs48c" title="Warrant issuance date">March 25, 2020</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zmDfvAZpdHVa" title="Shares of common stock issuable for outstanding warrants">44,150</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zo9XEW7xBdAb" title="Shares of common stock issuable for outstanding warrants">44,150</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_z35W6csCZRa6" title="Exercise price">1.40</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--March252020Member_zlyawo2OwiDf" title="Expiration date">March 24, 2030</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_909_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zXzAgLSz1aD4" title="Warrant issuance date">February 12, 2021</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zVqNjqSDXPCd" title="Shares of common stock issuable for outstanding warrants">173,205</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zBtMBYcZJTwe" title="Shares of common stock issuable for outstanding warrants">173,205</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_zCcHhVEG3fHa" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--February122021Member_z6jT4Z2nuEU2" title="Expiration date">February 12, 2031</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_905_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_z6E8aN5RIYnh" title="Warrant issuance date">June 25, 2021</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zBhDLVtH3RSb" title="Shares of common stock issuable for outstanding warrants">288,721</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zBUg7OgpAR05" title="Shares of common stock issuable for outstanding warrants">288,721</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zf1z2hPu8wB3" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--June252021Member_zzcxZV72AXuk" title="Expiration date">June 25, 2031</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span id="xdx_901_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zlS939ABfTo5" title="Warrant issuance date">August 16, 2021</span></td><td style="white-space: nowrap; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zBkk089qalhg" title="Shares of common stock issuable for outstanding warrants">22,427</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_z3NVhsTGN517" title="Shares of common stock issuable for outstanding warrants">22,427</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zi6he07btIlf" title="Exercise price">5.90</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--August162021Member_zBUPCm98tMvg" title="Expiration date">June 25, 2031</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90B_ecustom--WarrantIssuanceDate_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_z0fkzA7Yrkcj" title="Warrant issuance date">October 4, 2021</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_zg9NUDk1vpVl" title="Shares of common stock issuable for outstanding warrants">311,148</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_zPs59ZRMOWK8" title="Shares of common stock issuable for outstanding warrants">311,148</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_zLnAB7p40uac" title="Exercise price">5.90</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--AwardDateAxis__custom--October42021Member_z0Zx2MOEXl02" title="Expiration date">October 4, 2031</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt; text-indent: 18pt">Total</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zr6cmtdFzdc1" title="Shares of common stock issuable for outstanding warrants">1,947,853</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--SharesOfCommonStockIssuableForOutstandingWarrants_pid_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDm0KSgDlYVh" title="Shares of common stock issuable for outstanding warrants">1,947,853</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2016-06-30 3639 3639 8.20 2026-06-30 2017-10-30 195061 195061 4.10 2027-10-29 2018-02-28 23418 23418 8.20 2028-02-28 2019-08-26 443790 443790 5.90 2029-08-26 2020-03-13 442294 442294 5.90 2030-03-13 2020-03-25 44150 44150 1.40 2030-03-24 2021-02-12 173205 173205 5.90 2031-02-12 2021-06-25 288721 288721 5.90 2031-06-25 2021-08-16 22427 22427 5.90 2031-06-25 2021-10-04 311148 311148 5.90 2031-10-04 1947853 1947853 5.64 P4Y1M2D <p id="xdx_80F_eus-gaap--IncomeTaxDisclosureTextBlock_zVqeblNXvqfd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Note 13 - <span id="xdx_82C_zc8HdDRbDwWd">Income taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">During the three months ended March 31, 2026 and 2025, the Company does not have an income tax benefit or expense. The Company has historically incurred net operating losses and maintains a full valuation allowance against its net deferred tax assets. Valuation allowances are recorded when the expected realization of the deferred tax assets does not meet a “more likely than not” criterion. Realization of the Company’s deferred tax assets are dependent upon the generation of future taxable income, the amount and timing of which are uncertain. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company’s effective tax rate was <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_c20260101__20260331_zKnVNY1cwDJ2" title="Effective tax rate"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_c20250101__20250331_zLuGgK3qVz0b" title="Effective tax rate">0%</span></span> for the three months ended March 31, 2026 and 2025. The difference between the effective tax rate and the federal statutory rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_c20260101__20260331_zd8QTcyA9dZ8" title="Valuation allowance">21%</span> was primarily due to the full valuation allowance recorded on the Company’s net deferred tax assets, state and foreign tax benefits, research and development tax credits, and other non-deductible expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">During the three-month period ended March 31, 2026, there were <span id="xdx_90A_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pn3n3_do_c20260331_zuVFYCMnDPp7" title="Uncertain tax positions">no</span> material changes to the Company’s uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The One Big Beautiful Bill Act (“OBBA”) includes significant U.S. tax provisions, including the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework, and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates from 2025 through 2027. The Company continues to monitor any new tax laws and notes those effective in 2026 do not have a material impact on the Company’s unaudited condensed consolidated financial statements for the three months ended March 31, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 0 0 0.21 0 <p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_zqN8frphN8U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 14 - <span id="xdx_824_zSVeaJI3VWCj">Net loss per share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following tables sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three months ended March 31, 2026 and 2025 (in thousands, except per share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zfsqzqnArnnc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Net loss per share (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"><span id="xdx_8B9_zOoxXsQGnxHj" style="display: none">Schedule of basic and diluted net loss per share</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Numerator – basic &amp; diluted:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Net loss attributable to common stockholders, basic and diluted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_909_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20260101__20260331_zGj0cRRsVMY9" title="Net loss attributable to common stockholders, basic"><span id="xdx_904_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_c20260101__20260331_zjKs839keEdc" title="Net loss attributable to common stockholders, diluted">(17,074</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20250101__20250331_zoWlOdqwolWh" title="Net loss attributable to common stockholders, basic"><span id="xdx_905_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_c20250101__20250331_zkJaJRmaGed6" title="Net loss attributable to common stockholders, diluted">(10,554</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average number of shares outstanding, basic and diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20260101__20260331_zBLsAJqrUygd" title="Weighted-average number of shares outstanding, basic"><span id="xdx_905_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_pid_c20260101__20260331_zNxizIlbO0o" title="Weighted-average number of shares outstanding, diluted">45,038,351</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250101__20250331_zBfh4TNy3Hs3" title="Weighted-average number of shares outstanding, basic"><span id="xdx_90C_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_pid_c20250101__20250331_z0rFobPeyLF6" title="Weighted-average number of shares outstanding, diluted">37,254,117</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20260101__20260331_zm61DQvvnsfj" title="Net loss per share attributable to common stockholders, basic"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20260101__20260331_zNsAGyyGYmia" title="Net loss per share attributable to common stockholders, diluted">(0.38</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20250101__20250331_zvgDoGfjprkj" title="Net loss per share attributable to common stockholders, basic"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20250101__20250331_zHj5mUlrugl3" title="Net loss per share attributable to common stockholders, diluted">(0.28</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AC_zu5WFtw4U3fa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding for the periods presented as the effect would have been anti-dilutive as of March 31, 2026 and 2025:</span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zceFIosYM5Q7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Net loss per share (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zn1ePGPQEtSb" style="display: none">Schedule of anti-dilutive shares</span></td><td style="color: black; padding-bottom: 1pt"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">March 31,<br/> 2026</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">March 31,<br/> 2025</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Outstanding warrants</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 15%; color: black; text-align: right"><span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7pxvls8qfz6" title="Total dilutive shares">1,947,853</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 15%; color: black; text-align: right"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zenG1yPBv8Ph" title="Total dilutive shares">1,978,938</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Outstanding stock options</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z7V5bOgRRVq9" title="Total dilutive shares">4,801,657</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zKYg4JQuLP7l" title="Total dilutive shares">4,036,616</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt; text-indent: 17.25pt">Total dilutive shares</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260331_zAj4bnAbcfzf" title="Total dilutive shares">6,749,510</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250101__20250331_zw1Y8zy4EP78" title="Total dilutive shares">6,015,554</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> <p id="xdx_8A4_z6PIC1gNTIM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zfsqzqnArnnc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Net loss per share (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"><span id="xdx_8B9_zOoxXsQGnxHj" style="display: none">Schedule of basic and diluted net loss per share</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Numerator – basic &amp; diluted:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Net loss attributable to common stockholders, basic and diluted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_909_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20260101__20260331_zGj0cRRsVMY9" title="Net loss attributable to common stockholders, basic"><span id="xdx_904_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_c20260101__20260331_zjKs839keEdc" title="Net loss attributable to common stockholders, diluted">(17,074</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20250101__20250331_zoWlOdqwolWh" title="Net loss attributable to common stockholders, basic"><span id="xdx_905_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_c20250101__20250331_zkJaJRmaGed6" title="Net loss attributable to common stockholders, diluted">(10,554</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average number of shares outstanding, basic and diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20260101__20260331_zBLsAJqrUygd" title="Weighted-average number of shares outstanding, basic"><span id="xdx_905_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_pid_c20260101__20260331_zNxizIlbO0o" title="Weighted-average number of shares outstanding, diluted">45,038,351</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250101__20250331_zBfh4TNy3Hs3" title="Weighted-average number of shares outstanding, basic"><span id="xdx_90C_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_pid_c20250101__20250331_z0rFobPeyLF6" title="Weighted-average number of shares outstanding, diluted">37,254,117</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20260101__20260331_zm61DQvvnsfj" title="Net loss per share attributable to common stockholders, basic"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20260101__20260331_zNsAGyyGYmia" title="Net loss per share attributable to common stockholders, diluted">(0.38</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20250101__20250331_zvgDoGfjprkj" title="Net loss per share attributable to common stockholders, basic"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20250101__20250331_zHj5mUlrugl3" title="Net loss per share attributable to common stockholders, diluted">(0.28</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -17074000 -17074000 -10554000 -10554000 45038351 45038351 37254117 37254117 -0.38 -0.38 -0.28 -0.28 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zceFIosYM5Q7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Net loss per share (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zn1ePGPQEtSb" style="display: none">Schedule of anti-dilutive shares</span></td><td style="color: black; padding-bottom: 1pt"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="color: black; text-align: left"> </td><td style="color: black; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">March 31,<br/> 2026</td><td style="white-space: nowrap; color: black; text-align: left"> </td><td style="white-space: nowrap; color: black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: black; text-align: center">March 31,<br/> 2025</td><td style="white-space: nowrap; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; color: black; text-align: left">Outstanding warrants</td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 15%; color: black; text-align: right"><span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7pxvls8qfz6" title="Total dilutive shares">1,947,853</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td><td style="width: 1%; color: black"> </td> <td style="width: 1%; color: black; text-align: left"> </td><td style="width: 15%; color: black; text-align: right"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zenG1yPBv8Ph" title="Total dilutive shares">1,978,938</span></td><td style="white-space: nowrap; width: 1%; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left; padding-bottom: 1pt">Outstanding stock options</td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z7V5bOgRRVq9" title="Total dilutive shares">4,801,657</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zKYg4JQuLP7l" title="Total dilutive shares">4,036,616</span></td><td style="white-space: nowrap; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; padding-bottom: 2.5pt; text-indent: 17.25pt">Total dilutive shares</td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260331_zAj4bnAbcfzf" title="Total dilutive shares">6,749,510</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td><td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250101__20250331_zw1Y8zy4EP78" title="Total dilutive shares">6,015,554</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> 1947853 1978938 4801657 4036616 6749510 6015554 <p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zppuONT1NXfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 15 - <span id="xdx_826_zwKKEy2iC1M1">Segment information</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The Company's chief operating decision maker (“CODM”) is the Chief Executive Officer. The Company has determined that it has a single operating and reportable segment. The CODM uses revenue, gross margin and operating expenses at the consolidated level to allocate resources, monitor budget versus actual results, and manage operations. Significant expenses within operating expenses include engineering and development, clinical and regulatory, sales and marketing, and general and administrative expenses at the consolidated level. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">Substantially all of the segment revenue is derived from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. International revenue accounted for less than 5% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The following table summarizes the Company's revenue by geography for the three months ended March 31, 2026 and 2025 (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--RevenueFromExternalCustomersByGeographicAreasTableTextBlock_pn3n3_zpkNJHsnC3X" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span id="xdx_8BA_z1DeLUzcWjGe" style="display: none">Schedule of segment revenue by geography based</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--StatementGeographicalAxis__country--US_zgn2sPkSxire" title="Total Revenue">2,359</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--StatementGeographicalAxis__country--US_zJlaqY6eyhp5" title="Total Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">International</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--StatementGeographicalAxis__custom--InternationalMember_zCOW7HWvJfH" title="Total Revenue">3</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--StatementGeographicalAxis__custom--InternationalMember_zZ6C85xNLM7f" title="Total Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--Revenues_pn3n3_c20260101__20260331_zM2YfFX1TEwi" title="Total Revenue">2,362</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331_z3RSZzQ3PEff" title="Total Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1447">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_ziHXs2eDXC13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The following table disaggregates amounts that comprise research and development, and selling, general and administrative expenses within the accompanying unaudited condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zYWP5hYzBmE8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zRWIkIpbYU2" style="display: none">Schedule of segment information</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Engineering and development</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--EngineeringAndDevelopmentMember_zNy0w0TksEuh" title="Total research and development expenses">3,989</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--EngineeringAndDevelopmentMember_zhsj23tyNS6b" title="Total research and development expenses">3,257</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Clinical and regulatory</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--ClinicalAndRegulatoryMember_zfUYI7SB6gVk" title="Total research and development expenses">2,428</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--ClinicalAndRegulatoryMember_zVFB1EvTHD12" title="Total research and development expenses">2,162</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total research and development</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20260101__20260331_zS3zxSm9oRMd" title="Total research and development expenses">6,417</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20250101__20250331_zA0nICXpjhmf" title="Total research and development expenses">5,419</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--SellingAndMarketingMember_zysa5fHKd4Wf" title="Total selling, general and administrative">6,148</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_903_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--SellingAndMarketingMember_z3TXQfjvY90j" title="Total selling, general and administrative">1,489</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zOiHVQXg3d0b" title="Total selling, general and administrative">3,791</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zj10lWjpHXC1" title="Total selling, general and administrative">2,874</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total selling, general and administrative</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20260101__20260331_zVnmfHpDyiah" title="Total selling, general and administrative">9,939</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20250101__20250331_zUClnbIWCVFg" title="Total selling, general and administrative">4,363</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zdF06cMoKhJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The segment's net loss equals the Company’s net loss as presented in the unaudited condensed consolidated statements of operations. Other segment items within net loss include interest expense, interest income, and loss on foreign currency at the consolidated level.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--RevenueFromExternalCustomersByGeographicAreasTableTextBlock_pn3n3_zpkNJHsnC3X" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span id="xdx_8BA_z1DeLUzcWjGe" style="display: none">Schedule of segment revenue by geography based</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--StatementGeographicalAxis__country--US_zgn2sPkSxire" title="Total Revenue">2,359</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--StatementGeographicalAxis__country--US_zJlaqY6eyhp5" title="Total Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">International</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--Revenues_pn3n3_c20260101__20260331__srt--StatementGeographicalAxis__custom--InternationalMember_zCOW7HWvJfH" title="Total Revenue">3</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--Revenues_pn3n3_c20250101__20250331__srt--StatementGeographicalAxis__custom--InternationalMember_zZ6C85xNLM7f" title="Total Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--Revenues_pn3n3_c20260101__20260331_zM2YfFX1TEwi" title="Total Revenue">2,362</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--Revenues_pn3n3_c20250101__20250331_z3RSZzQ3PEff" title="Total Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1447">-</span></span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2359000 3000 2362000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zYWP5hYzBmE8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment information (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zRWIkIpbYU2" style="display: none">Schedule of segment information</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Three Months Ended March 31,</td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2026</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2025</td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Engineering and development</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--EngineeringAndDevelopmentMember_zNy0w0TksEuh" title="Total research and development expenses">3,989</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--EngineeringAndDevelopmentMember_zhsj23tyNS6b" title="Total research and development expenses">3,257</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Clinical and regulatory</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--ClinicalAndRegulatoryMember_zfUYI7SB6gVk" title="Total research and development expenses">2,428</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--ClinicalAndRegulatoryMember_zVFB1EvTHD12" title="Total research and development expenses">2,162</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total research and development</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20260101__20260331_zS3zxSm9oRMd" title="Total research and development expenses">6,417</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20250101__20250331_zA0nICXpjhmf" title="Total research and development expenses">5,419</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--SellingAndMarketingMember_zysa5fHKd4Wf" title="Total selling, general and administrative">6,148</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_903_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--SellingAndMarketingMember_z3TXQfjvY90j" title="Total selling, general and administrative">1,489</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20260101__20260331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zOiHVQXg3d0b" title="Total selling, general and administrative">3,791</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20250101__20250331__custom--IncomeStatementLocationsAxis__custom--GeneralAndAdministrativeMember_zj10lWjpHXC1" title="Total selling, general and administrative">2,874</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 18pt">Total selling, general and administrative</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20260101__20260331_zVnmfHpDyiah" title="Total selling, general and administrative">9,939</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20250101__20250331_zUClnbIWCVFg" title="Total selling, general and administrative">4,363</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3989000 3257000 2428000 2162000 6417000 5419000 6148000 1489000 3791000 2874000 9939000 4363000 <p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zaETWiqnLAl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 16 - <span id="xdx_823_zq8sQimNCs38">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b><i>Purchase commitments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company</span> purchases raw materials, manufacturing equipment, and various services from a variety of vendors. During the normal course of business, in order to manage manufacturing lead times and help ensure an adequate supply of certain items, we enter into agreements with suppliers that either allow us to procure goods and services when we choose or that establish purchase requirements over the term of the agreement. In certain instances, our purchase agreements allow us to cancel, reschedule, or adjust our purchase requirements based on our business needs prior to firm orders being placed. Consequently, only a portion of our purchase commitments are firm and non-cancelable. <span style="background-color: white">As of March 31, 2026, the Company’s obligations under such arrangements were approximately $<span id="xdx_90C_eus-gaap--PurchaseObligation_iI_pn3n3_dm_c20260331_z3BNHdTZprMe" title="Obligations">14.0</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Cybersecurity</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company detected a cybersecurity incident in which an unauthorized third party gained access to certain information systems of the Company on or around February 13, 2026. Upon detection, the Company promptly initiated response protocols and began taking steps to contain, assess and remediate the cybersecurity incident, including launching an investigation with external cybersecurity experts. Although the Company believes that the cybersecurity incident has not had a material impact on its overall financial condition or results of operations, its evaluation and response to this incident are ongoing and the Company may discover other impacts or new events related to this incident may occur that could affect the Company’s financial condition or results of operations. As of March 31, 2026, incurred cybersecurity expenses limited to the Company’s insurance deductibles have been recorded and reflected within the Company’s unaudited condensed consolidated financial statements and such amounts are not material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Contingencies</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #231F20">The Company is party to various legal proceedings from time to time. A liability is accrued when a loss is both probable and can be reasonably estimated. Management believes that the probability of a material loss with respect to any currently pending legal proceeding is remote. However, litigation is inherently uncertain, and it is not possible to definitively predict the ultimate disposition of any of these proceedings. The Company does not believe that there are any pending legal proceedings or other loss contingencies that will, either individually or in the aggregate, have a material adverse impact on the Company’s unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 14000000.0 <p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zDKm0Woa07Ej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Note 17 – <span id="xdx_82D_zenecQwmM3A4">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">See Note 1 – Business and organization – <i>“Reverse stock split”</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On May 6, 2026, stockholders approved the addition of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_c20260501__20260506__us-gaap--PlanNameAxis__custom--Plan2021Member_zFeoFcptXQ5g" title="Reverse stock split shares">1,801,036</span> shares of common stock, as adjusted for the Reverse Stock Split, to the number of shares of common stock reserved for issuance under the 2021 Plan, by operation of the “evergreen” provision set forth in the 2021 Plan.</span></p> 1801036 false false false false